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II. Abstract 
 
Programmed celular execution is one of the halmarks of celular homeostasis as wel as the 
development  of  multicelular  organisms.  To  date, two  major signaling pathways for 
programmed  cel  death  have  been  elucidated,  namely  apoptosis  and  necroptosis.  The 
induction of these two regulated cel death programs can be initiated by a variety of extrinsic 
as wel as intrinsic stimuli, like genotoxic stress, death receptor activation, pathogen infection 
or the  depletion  cIAPs.  Apoptosis thereby relies  on the  activation  of  caspase-8,  which 
induces  a  downstream  caspase  cascade, finaly leading to  apoptotic execution. In contrast, 
caspase-independent  necroptosis relies  on the  activation  of the  kinases  RIP1  and  RIP3, 
resulting in the phosphorylation of the pseudokinase MLKL. This finaly leads to necroptotic 
plasma  membrane  permeabilization.  Additionaly, recent  studies  highlighted that  certain 
celular conditions can induce the formation of an intracelular 2 MDa multi-protein complex, 
caled  Ripoptosome,  which  can lead to  apoptosis  as  wel  as  necroptosis  based  on the 
stoichiometric  composition.  This  protein  complex  consists  of  FADD,  caspase-8,  cFLIP  and 
the  name  giving  RIP1.  However, it is  stil  unclear, if  al  components  or interacting  proteins 
have been identified. 
In this  study  purified  Ripoptosome  complexes  were analyzed for the identification  of  novel 
components  by  mass  spectrometry. Interestingly, the  non-canonical IKKs;  TBK1  and IKK-ε 
as wel as TRAF2 could be identified as integral elements of the complex. The association of 
these  molecules  with the  Ripoptosome  was  observed  upon  TNF treatment  or  TLR3 
stimulation or the overexpression of RIP1 as the initial stimulus. Moreover, the non-canonical 
IKKs were highly phosphorylated in the complex, arguing for substantial activation. The cel 
death regulating function of the Ripoptosome was not afected by the loss of TBK1 and IKK-
ε, indicating that these  molecules  could  play  a  pivotal role in  non-cel  death  signaling 
pathways. In contrast, decrease of TRAF2 resulted in a sensitization against apoptotic cels 
death.  This  was true for the  expression  of  RIP1  as  wel  as the  combined treatment  of  poly 
(I:C) or TNF with IAP antagonists. Additionaly, RIP1-induced  Ripoptosome formation  could 
be linked to the  activation  of  NF-κB and the induction  of inflammatory  cytokines. The 
reduction in TBK1 and IKK-ε protein levels was leading to a decrease in the RIP1-regulated 
gene induction.  Additionaly, the formation  of the  Ripoptosome  was inducing the 
phosphorylation of autophagy receptors optineurin and sequestosome-1. This activation was 
highly  depending on the  kinases  TBK1  and IKK-ε, indicating  a  possible  Ripoptosome-
dependent  activation  of the  autophagy  machinery.  The  novel identified  components 
highlighted the Ripoptosome as a key complex not only for cel death regulation, but also for 
cel death-independent signaling pathways such as inflammatory responses and autophagy. 
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IV. Zusammenfassung 
 
Programmierter  Zeltod (PCD) ist  ein  Bestandteil  der  zelulären  Homöostase,  sowie  der 
Entwicklung vielzeliger Organismen. Bis heute wurden hauptsächlich zwei PCD Signalwege 
detailiert  beschrieben,  und  zwar  die  Apoptose  und  die  Nekroptose.  Die Induktion  dieser 
Zeltodprogramme kann durch eine Vielzahl von extrinsischen und intrinsischen Stimuli, wie 
genotoxischem  Stress,  der  Aktivierung  von  Todesrezeptoren,  pathogenen Infektionen  oder 
der Depletierung von cIAPs (inhibitor of apoptosis protein) ausgelöst werden. Die Apoptose 
beruht  dabei im  Wesentlichen  auf  der  Aktivierung  der Initiator-Caspase-8,  welche  eine 
nachgeschaltete  Caspase-Kaskade  auslöst,  was  schließlich  zur  apoptotischen  Exekution 
führt. Im  Gegensatz  dazu  hängt  die  Caspase-unabhängige  Nekroptose  von  der  Aktivierung 
der Kinasen RIP1 und RIP3 ab. Nach der Aktivierung phosphoryliert RIP3 die Pseudokinase 
MLKL,  was letztendlich  zur  nekroptotischen  Permeabilisierung  der  Plasmamembran führt. 
Zusätzlich  haben  neue  Studien  gezeigt,  dass  bestimmte  zeluläre  Umstände  zur  Bildung 
eines  2  MDa  Komplexes,  dem  Ripoptosom, führen  können,  der  basierend  auf seiner 
stöchiometrischen  Beschafenheit  zu  Apoptose  sowie  Nekroptose führen  kann.  Dieser 
Proteinkomplex  besteht  aus  FADD,  Caspase-8,  cFLIP  und  dem  namengebenden  RIP1. 
Alerdings ist  noch immer  unklar,  ob  neben  den  bekannten  Ripoptosomkomponenten  noch 
weitere Proteine vorhanden sind oder mit dem Ripoptosom interagieren. 
In  dieser  Studie  wurden  gereinigte  Ripoptosomkomplexe  massenspektrometrisch  auf 
mögliche  neue  Komponenten  untersucht. Interessanterweise  konnten  TBK1  und IKK-ε, 
sowie TRAF2 als Bestandteile dieses Komplexes identifiziert werden. Die Assoziation dieser 
Moleküle  mit  dem  Ripoptosom  konnte  nach  TNF  Stimulation,  TLR3  Aktivierung  und  nach 
Überexpression von RIP1 gefunden werden. Weiterhin waren TBK1 und IKK-ε im  Komplex 
stark  phosphoryliert.  Die  Ripoptosom-vermitelte  Zeltodantwort wurde  durch  den  Verlust 
dieser  Proteine  nicht  beeinflusst. Im  Gegensatz  dazu führte  die  Reduktion  von  TRAF2, 
sowohl  nach  Expression  von  RIP1, als  auch  nach  kombinierter  Behandlung  mit  poly (I:C) 
oder TNF und IAP Antagonisten, zu einer Sensitivierung gegenüber apoptotischem  Zeltod. 
Des Weiteren konnte die RIP1-induzierte Komplexformierung mit der Aktivierung von NF-κB 
und der Induktion inflammatorischer Zytokine verknüpft werden. Die Reduktion der TBK1 und 
IKK-ε Proteinlevel führte  zu  einer  Abnahme  der  RIP1-vermitelten  Geninduktion.  Weiterhin 
wurde  durch  Ripoptosomformierung  die  Phosphorylierung  von  Autophagierezeptoren,  wie 
Optineurin und Seqestosome-1, induziert. Diese Aktivierung war abhängig von den Kinasen 
TBK1 und IKK-ε. Somit beleuchten die neu identifizierten Komponenten das Ripoptosom als 
Schlüsselkomplex, nicht  nur für  die  Zeltodregulation  sondern  auch für  zeltodunabhängige 
Signalwege, wie Inflammation oder Autophagie. 
Introduction 
1 
V. Introduction 
 
V.1. Programmed Cel Death – a regulated way to die 
 
Multicelular  organisms  have  developed the  ability to remove  excessive,  abnormal  and 
potentialy dangerous cels in a highly regulated manner. Therefore, they use specific forms 
of programmed cel death (PCD), which can be triggered through intracelular sensors as wel 
as through  extracelular  stimuli.  To  date, there  are two  described intracelular signaling 
pathways,  named  apoptosis  and  necroptosis,  whose  stimulation  can lead to  directed  cel 
execution. Both difer in morphological appearance as wel as in their biochemical behavior. 
Recent studies highlighted the essential role of both forms of execution, as disorganization of 
these  processes  can lead to  embryonic lethality,  autoimmune  diseases  or  cancer 
development.  
 
V.1.1. Apoptosis – a caspase-dependent, regulated cel death program 
The importance  of regulated  cel  death for  celular  homeostasis  was first  described  by the 
German  Scientist  Karl  Vogt in  18421.  However, the importance  of this  discovery  was  not 
recognized until 1965  when  John  Foxten  Ross  Kerr  was  able to  distinguish regulated  cel 
death from traumatic  cel  execution2,3. In  1972, Kerr,  Whylie  and  Currie finaly  defined the 
term apoptosis for the observed regulated form of cel death4. The regulated removal of cels 
through  apoptosis is  normaly  conferring  advantages  during  an  organism’s lifecycle. 
Whenever  certain  cels  become  abnormal  and thereby  potentialy  dangerous, for  example 
through genetic mutations occurring during cel proliferation or after pathogen infection, they 
have to  be removed in  order to  protect the  surrounding tissue  or the  whole  organism. 
Moreover, it was shown that apoptosis is a necessity for embryonic development5. This can 
for example be seen, when the excessive cels in the interdigital zone have to be eliminated 
in an ordered fashion to separate the single fingers6. 
Cels undergoing apoptosis show characteristic morphological changes that can be divided in 
the folowing steps: First, cel shrinkage and rounding is observed as a cause of the caspase-
triggered breakdown of the cytoskeleton7. This is folowed by the condensation of chromatin8. 
The  DNA is fragmented  and the  nucleus  breaks into several  so-caled  chromatin  bodies8. 
The cel membrane loses the round structure and irregular blebs become visible (known as 
membrane blebbing)9.  The  cel  breaks into  several  vesicles (caled  apoptotic  bodies)  which 
are then  eliminated through  phagocytosis10,11. Once activated,  apoptosis is resulting in the 
activation  of  an intracelular regulatory  protein  cascade, where  cystein-aspartatic  proteases 
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(caspases)  play the  major role in  downstream  propagation  of the  death  signal12.  The 
caspases can be divided into initiator-caspases (2, 8, 9, and 10), effector-caspases (3, 6, and 
7) and inflammatory-caspases13. Caspases are always synthesized in their inactive proform, 
caled  zymogen  or  procaspase,  which  can  be  brought into its  active  state  by  autocatalytic 
cleavage or via fission through other caspases. The prodomain of initiator caspases consists 
of  complex  binding  motives like the  death  efector  domain (DED)  or the  caspase recruiting 
domain (CARD), which are essential for the recruitment of these caspases into multiprotein 
complexes13. The initiation  of  apoptotic  execution  can  be  divided into two  major signaling 
pathways: the intrinsic  or  mitochondrial  pathway  and the  extrinsic  or  death receptor (DR) 
pathway14, which wil be discussed in the folowing chapters. 
 
V.1.1.1. The intrinsic apoptotic signaling pathway 
Pathogen infections  or inflammatory  cytokines  as  wel  as intracelular  stimuli like  DNA 
(Deoxyribonucleic acid) damage or the production of reactive oxygen species (ROS) are able 
to induce the intrinsic  apoptotic signaling pathway14,15.  The  above-mentioned  stress factors 
result in the  activation  of the  BH3-only (B-cel lymphoma-2 (Bcl-2)  homology  3 (BH3)-only) 
proteins16,17.  These  proteins in turn  activate the  pro-apoptotic  proteins  Bak (Bcl-2 
homologues antagonist kiler) and Bax (Bcl-2 associated X protein). Both proteins are able to 
integrate  and form  porous  structures in the  mitochondrial  outer  membrane18.  This  process 
results in the release  of  apoptogenic factors,  e.g.  Cytochrome-c  or  Smac/Diablo (second 
mitochondria-derives  activator  of  caspases/direct IAP  binding  protein  with low  pI) from the 
mitochondrial inter  membrane  space (IMS)19.  The release  of  Cytochrome-c  alows the 
formation  of the  so-caled  Apoptosome,  consisting  of  Apaf-1 (apoptotic  protease  activation 
factor 1)20, Cytochrome-c21 and procaspase-922. Activation of caspase-9 in the Apoptosome 
enables the  activation  of downstream  executioner-caspases-3  and -7.  These  caspases 
further activate endonucleases such as the caspase-activated DNase (CAD) in line with the 
cleavage  of  cytokeratins,  as  wel  as  nuclear- and  plasma  membrane  cytoskeletal  proteins, 
finaly leading to the previously described DNA fragmentation and breakdown of the nuclear 
structure23,24. 
One can easily envision that the described mechanisms have to be controled very tightly in 
order to inhibit  spontaneous  apoptosis through Apoptosome formation  or  activation  of 
executioner caspases-3 and -7. Therefore, the apoptotic inhibitor XIAP (X-linked inhibitor of 
apoptosis  protein)25 is  normaly  binding  and thereby inhibiting the  caspases-3, -7  and -926. 
Once the intrinsic apoptotic pathway is activated, the release of the above-mentioned protein 
Smac/Diablo from the IMS is  sequestering the  protective function  of  XIAP  by  direct 
inactivation27,28 (Figure 1).  
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V.1.1.2. The extrinsic apoptotic pathway 
The  activation  of  cel  death  by the  extrinsic  apoptotic  pathway relies  on the  stimulation  of 
death receptors, like  CD95 (cluster  of  diferentiation  95),  which  are located  on the  cel 
surface. After binding of specific death ligands (DL), these receptors initiate the formation of 
cytosolic, death inducing signaling complexes (DISC). The stimulation of the receptor results 
in the intracelular binding of the adaptor molecule FADD (Fas-associated protein with death 
domain)29 via its death domain (DD) to the intracelular DD of the trimerized receptor30. FADD 
in turn recruits procaspase-8 via mutual interaction of the DEDs harbored by both proteins31. 
The local increase of procaspase-8 level induces the autocatalytic cleavage of the large and 
smal  catalytic  subunit folowing the formation  of the  active  caspase-8  homodimer.  Active 
caspase-8 can now propagate the apoptotic signal by the cleavage of efector-caspases, e.g. 
caspase-3 and -732,  which in turn  can  cleave their target  substrates for  apoptotic  execution 
(Figure 1).  
 
V.1.1.3. Crosstalk between the intrinsic and the extrinsic apoptotic pathway 
Cel  execution,  carried  out  by the  above-mentioned  pathways, is  not  strictly folowing  only 
one signaling cascade. There is rather a dynamic crosstalk that is mainly depending on the 
pro-apoptotic  Bcl-2 family  member BH3 interacting-domain  death  agonist (Bid)33,34.  Bid is  a 
direct substrate of caspase-835. Cleavage of Bid through caspase-8, results in the truncated 
form  of  Bid (tBid). tBid is  subsequently  activating  Bak  and  Bax, resulting in the  above-
mentioned release  of apoptogenic factors, like  Cytochrome-c36 and  Smac/Diablo from the 
IMS, thereby increasing the  apoptotic  signal.  Furthermore  activated  caspase-6,  a  protein 
classicaly found in the intrinsic  pathway,  can  cleave  procaspase-837,  providing  a  celular 
feedback loop, again resulting in the reinforcement of apoptotic cel death (Figure 1). 
 
V.1.2. Necroptosis – a caspase-independent form of programmed cel death 
The last  years  have  shown that  besides the  dominant  apoptotic  cel  death,  another  PCD 
pathway is  present. It  was termed  necroptosis to  stress the  morphological  similarity to the 
classical  phenotype  of  unregulated  necrotic  cel  death38.  When  apoptosis is  blocked  by the 
inhibition of caspase activity, necroptosis can act as a backup mechanism39, ensuring celular 
execution due to pathogen infections or celular pathophysiology. Therefore, the induction of 
necroptotic  cel  death  can  be triggered  by the  same  stimuli  as  apoptosis,  namely  DR 
activation or genotoxic stress40. 
As mentioned above, the morphology is similar to the one found during unregulated necrotic 
cel  death.  As  a first  step  cel rounding is  observed, folowed  by  cytoplasmic  sweling.  This 
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finaly results in the disintegration of intracelular compartments as wel as the rupture of the 
plasma membrane, resulting in the spiling of intracelular content41. 
On the molecular level, the propagation of necroptosis is, in contrast to apoptosis, completely 
caspase-independent. Instead, the  necroptotic signaling pathway relies  on the  stabilization 
and  activation  of the  kinases  RIP1 (Receptor Interacting  Protein  1)  and  RIP3 (Receptor 
Interacting Protein 3)42. Under physiological conditions, both kinases are regulated by active 
caspase-8 homodimers. RIP1 and RIP3 can be directly cleaved and thereby inactivated by 
caspase-843,44.  Moreover,  celular inhibitors  of  apoptosis  proteins (cIAP)  are important 
regulators  of  RIP1.  cIAPs (especialy  cIAP1/2)  are  classicaly  defined  as  anti-apoptotic 
proteins,  as they  harbor, in line  with  XIAP, the  ability to  bind  and thereby inactivate the 
executioner-caspases-3, -7  and -945.  Additionaly, the  mentioned  cIAP1/2  proteins  are 
responsible for  constitutive  RIP1  ubiquitination,  which in turn leads to proteasomal RIP1 
degradation46. Summarized, both regulatory  mechanisms  ensure the  prevention  of 
necroptotic cel death by the tight regulation of the intracelular RIP1 and RIP3 level. Celular 
conditions, especialy genotoxic stress or ROS production, might lead to the depletion of the 
celular pool of cIAPs, which in combination with the inhibition of caspase activity, results in 
increased RIP1 and RIP3 level and the propagation of necroptotic cel death40,42. Stabilization 
of  RIP1  promotes the  binding  of  RIP347.  This leads to the formation  of the  so-caled 
Necrosome.  Within this  complex,  RIP3  can  be  phosphorylated  and thereby  activated  by 
RIP148.  The  activated form  of  RIP3 is  now  able to further  phosphorylate the  pseudokinase 
MLKL (Mixed  Lingase  Kinase Ligase)49.  The  activation  of MLKL results in the 
homodimerization  of the  pseudokinase,  engaging the formation  of  porous  structures50,51. 
These  structures  are finaly  guided to intracelular  membranes as  wel  as the  plasma 
membrane52,53, leading to their disruption and thereby cel execution50 (Figure 1). 
The concept of necroptosis was always extensively discussed as many people argued that 
the  depletion  of  cIAPs in  combination  with  caspase inhibition  displays  a rather 
unphysiological  condition.  However, recent  studies  showed that  mice, lacking  RIP1,  one  of 
the  main  components  of this  PCD,  are  born  normal  but  die at the  age  of  1-3  days,  due to 
high  TNF  driven  apoptosis54.  Moreover,  knockout  studies in  mice  have revealed that the 
regulation of necroptotic cel death plays a direct role in the inflammatory responses due to 
viral infections48,55.These findings  show that  besides the  backup function, there is  a 
physiological relevance for necroptotic cel death, especialy during inflammatory events56. 
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V.1.3. Autophagy – a celular recycling program with the ability to kil 
The term autophagy normaly refers to the process of autodigestion of celular components. It 
is the  only  mechanism that  enables the recycling  of  celular  organeles,  such  as the 
mitochondria, in  order to  eliminate  deficient  structures and, more important, to  provide 
nutrients to prolong a cels life cycle57. Thereby, the ubiquitination of damaged structures or 
protein  aggregates is the  major trigger for  autophagy induction.  Optineurin (OPTN), for 
example, is recruited to ubiquitinated sites on damaged mitochondria, thereby targeting the 
autophagic  machinery to the  deficient  organele58. In respect to  misfolded proteins, the 
autophagic receptor  sequestosome-1 (SQSTM1  or  p62)  co-localizes  with  ubiquitinated 
protein aggregates in a similar way, thereby again labels them for autophagic degradation59. 
Altogether, certain  celular  conditions like  high temperature60,  starvation  or  even  bacterial 
infections61 can provoke autophagy initiation by the formation of double membrane cytosolic 
vesicles,  caled  autophagosomes62.  They  are  able to  engulf  celular  components  or 
pathogens, which are then targeted to the lysosomes for digestion. This autophagic process 
guarantees the  availability  of important nutritious  components,  which  are  necessary for  cel 
viability, and induces the  clearance  of  damaged  or  misfolded  structures.  Meaning that 
autophagy classicaly functions as a pro-survival program, ensuring cel maintenance under 
stress  conditions63.  On the  other  site, there  are  some recent  studies  highlighting the 
presence  of  an  autophagy related  PCD  program.  This  autophagic  cel  death is  stil 
controversialy discussed, because it is not conclusively clarified whether autophagic activity 
in dying cels is the cause of death or a prevention mechanism, trying to rescue the cels64. 
However, cels lacking the pro-apoptotic proteins Bak and Bax, meaning that these cels are 
sequestered in their  apoptotic response,  show the formation  of  autophagosomes  when 
treated  with  apoptosis inducing  stimuli65.  The  same  efect  was  achieved  by the 
overexpression of the apoptosis inhibitors Bcl-2 or Bcl-xL in WT (wild type) cels65,66. Of note, 
autophagic death was not observed in WT cels when caspases were inhibited, arguing that 
autophagic death is not a direct consequence of apoptosis inhibition but rather regulated by 
proteins of the Bcl-2 family. This form of cel death is directly depending on the formation of 
the  autophagic  vesicles.  Pharmacological  autophagy inhibitors  such  as  3-methyladenin  or 
gene silencing of critical components of the autophagy machinery such as Atg5 (autophagy 
related 5) and Atg6 (autophagy related 6)65, result in the repression of this form of PCD. Even 
if the evidence for autophagic cel death is stil under controversial discussion, there are a lot 
of crossroads between cel death pathways and autophagy67,68. 
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V.2. Formation  of  multiprotein  complexes is the  starting  point  of 
programmed cel death signaling 
 
V.2.1.TNF complex I/I 
About 30 years ago, it was found that a specific cytokine named TNF (tumor necrosis factor), 
which was released from immune cels after stimulation, showed significant cytotoxicity on a 
variety of tumor cel lines 69,70. To date, it is known that there are two specific receptors on the 
cel  surface,  named  TNF receptor  1  and  2 (TNFR1/2),  which  are responsible for the  TNF 
binding  and the intracelular  signal transduction71,72.  TNFR1 is  constitutively  expressed in 
most tissues,  whereas  TNFR2 is  highly regulated  and  mostly found in  cels  of the immune 
system. Therefore, TNFR1 signaling wil be discussed in detail in the folowing section. 
TNFR1 activation executes a large spectrum of bioactivities. However, the most striking ones 
are the induction  of inflammatory responses  and,  depending  on the  celular  conditions, the 
induction  of  apoptosis  or  necroptosis73–75.  The  binding  of  TNF to  TNFR1, leads to the 
trimerization  of the receptor,  which in turn  creates  an intracelular  cluster  of  death  domains 
(DD).  This  cluster is  used  as  a  docking  station for the formation  of  a receptor  bound 
multiprotein  complex.  This  so-caled  complex I  consists  of the  adaptor  molecule  TRADD 
(TNFR 1-associated death domain protein), RIP1, TRAF2 (TNF associated factor 2), cIAP1 
and  cIAP2.  TRADD is recruited  via its  DD to the intracelular  part  of the receptor76.  This 
enables the binding of RIP1 to the DD of TRADD. Additionaly TRAF2, an E3 ubiquitin ligase 
that interacts with cIAPs, is recruited to the receptor via TRADD76. TRAF2 and the cIAPs are 
now responsible for the  addition  of  K63-linked  polyubiquitin chains to  RIP1  and  other 
components of the complex. This in turn enables the recruitment of LUBAC (linear ubiquitin 
chain assembly complex), which is adding M1-linear polyubiquitin chains to RIP177,78. These 
linear ubiquitin chains are essential for the recruitment of the IKK-complex and thereby NF-
κB (nuclear factor of kappa-light-chain-enhancer of activated B-cels) activation79 (Figure 2). 
However, it was shown that the depletion of cIAPs in combination with TNF stimulation can 
induce programmed cel death. The lack of cIAPs massively decreases the NF-κB response, 
due to the inability to recruit LUBAC77. Instead, the signaling complex can be released from 
the receptor, leading to the recruitment  of  caspase-8,  cFLIP (celular  FLICE (FADD-like IL-
1β-converting  enzyme)-like inhibitory  protein))  and  FADD80.  This  cytosolic  complex is 
referred to as complex Ia46. Within the complex, procaspase-8 can be cleaved into its active 
form, resulting in the  propagation  of  apoptotic  cel  death80.  Depending  on the  cFLIP  status 
(described in a separate chapter) or when caspase activity is now additionaly inhibited, RIP1 
is  stabilized 81.  This triggers the  binding  of  RIP3 to form the  Necrosome,  which is  also 
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referred to as complex Ib (Figure 2). Within this complex, RIP1 and RIP3 are subsequently 
activated, promoting the phosphorylation of MLKL. Active MLKL can now homodimerize and 
build up porous structures, which finaly lead to necroptotic execution50 (Figure 2). 
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V.2.2. DISC formation after CD95 receptor stimulation 
In line with the above-described TNF, other death inducing receptors were identified. One of 
the most prominent ones is CD95, a receptor that belongs to the TNF receptor superfamily. 
CD95 is the prototypic death receptor, as its main and best-studied function is the induction 
of  apoptosis.  Binding  of the  CD95 ligand (CD95L) to the  pre-organized receptor trimers  on 
the cel surface is leading to the intracelular recruitment of the adapter molecule FADD via 
its C-terminal DD domains29. Now caspase-8 can be recruited to FADD via mutual interaction 
of their  DED  domains82.  Additionaly,  RIP183 and  cFLIP84 are recruited to form the 
intracelular  death inducing  signaling  complex (DISC)85.  Within the  DISC,  procaspase-8 is 
subsequently activated, leading to the cleavage of downstream efector-caspases and finaly 
to  apoptotic  execution86. In line  with the  TNF  complex I, the  CD95  DISC  can  also induce 
necroptotic cel death87. Depending on the cFLIP level in the complex and under repression 
of  caspase  activity,  RIP1  and  RIP3  can form the  Necrosome to  activate  MLKL,  promoting 
plasma  membrane  disruption  and  necroptosis (Figure  3). Besides the  death-inducing 
function, the activation of the CD95 DISC can also result in the activation of the transcription 
factor NF-κB88.  It was shown that IκB-α is degraded after CD95L stimulation, leading to the 
induction of NF-κB target genes and inflammatory cytokine production89–91. However, it is stil 
unclear, how the signal is propagated from the DISC to IκB-α and whether this is carried out 
by the IKK complex or not (Figure 3).  
 
V.2.3. cFLIP – a negative regulator of DISC and TNF complex I PCD signaling 
The  activation  of  caspase-8  during  DISC  or  TNF  complex  signaling is  negatively regulated 
via cFLIP. Many diferent isoforms have been reported, however, cFLIPs and cFLIPL are the 
most frequent and best studied ones. cFLIPL (cFLIP long) contains a caspase-8-like domain 
lacking the  enzymatic  activity92.  This  domain is  completely  absent in  cFLIPs (cFLIP  short). 
Both isoforms contain two  DED  domains for  protein interactions.  Upon  complex formation, 
they can  be recruited into  multiprotein-complexes  similar to  caspase-8  via their  DEDs to 
FADD92–94. Moreover, cFLIP can form heterodimers with procaspase-8, thereby inhibiting or 
modulating caspase-8 activation. The overexpression of cFLIPL, for instance, was shown to 
completely block cel death. The formation of caspase-8/cFLIPL heterodimers is suficient to 
cleave RIP1, thereby preventing necroptotic execution. However, the activity is not suficient 
to activate caspase-8. Therefore, apoptosis is inhibited, leading to a complete abrogation of 
cel  death. In terms  of dominant  emplacement  of  cFLIPS into the  complex,  necroptotic  cel 
death is  promoted in  absence  of  cIAPs87.  Caspase-8/cFLIPS heterodimers  also  block 
caspase-8  activation. In  contrast to cFLIPL, these  dimers  are  not  able to  cleave  RIP1. 
Thereby, RIP1 is stabilized, resulting in the activation of RIP3 and finaly necroptosis95. 
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V.2.4. The Necrosome – Amyloid structures leading to programmed necrosis 
As mentioned above, caspase-8 is constantly cleaving RIP1 in death inducing complexes to 
prevent necroptotic cel death43,44. Under conditions where caspase function is inhibited, 
RIP1 and RIP3 are geting stabilized and are able to bind each other to form the 
Necrosome96. Both proteins are binding each other via their RHIM domains (RIP homotypic 
interaction motives), resulting in the formation of amyloid structures97,98. These are 
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filamentous protein aggregates, formed by cross-# structures97. As mentioned above, RIP1 
and RIP3, within this complex auto- and transphosphorylate each other, leading to the 
activation of MLKL and finaly to necroptotic execution50. 
 
V.2.5. The Ripoptosome 
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Many important functions are executed by the above-mentioned signaling platforms, such as 
the  death-inducing signaling complex (DISC),  TNF  complex I/I  or the  Necrosome  during 
necroptotic execution. In the last decade many studies have provided evidence that another 
intracelular  complex is formed  after  stress signaling or  cel  death induction. It  was  named 
Ripoptosome,  because  RIP1 is the  central  component  and  by inhibiting the  RIP1  kinase 
activity the assembly of the complex can be decreased or even fuly blocked99. The total size 
of the Ripoptosome is 2 MDa and it consists, besides the name giving RIP1, of the proteins 
FADD,  caspase-8,  cFLIP,  cIAP1  and  cIAP2.  Ripoptosome formation can  be induced and 
accelerated through a variety of extrinsic and intrinsic stimuli like DNA damage, depletion of 
celular IAPs,  overexpression  of  RIP1,  TLR3  stimulation  or  death ligand  binding to their 
specific receptors99,100 (Figure 4). It was shown that the mode of cel death, that is induced by 
the Ripoptosome, is mainly driven by the complex composition, especialy the stoichiometry 
of the  cFLIP isoforms92,95.  As  described  above,  caspase-8/cFLIPL heterodimer formation 
promotes  a total inhibition  of  cel  death,  caspase-8/cFLIPS heterodimers favour  necroptosis 
and caspase-8 homodimerization leads to the execution of apoptosis95. 
 
V.2.6. TLR3 signaling 
As a first line of defense against pathogens, the immune system of multicelular organisms 
has  evolved two  branches in  order to recognize  pathogenic  microorganisms,  namely the 
innate  and the  adaptive immune  system.  The innate immune  system is  phylogeneticaly 
conserved  and found in  almost  al  multicelular  organisms.  However, innate immunity  was 
long time thought to be quite non-specific, with the main roles in destroying pathogens and 
presenting  pathogenic  peptides  on the  cel  surface for recognition  by the  adaptive immune 
system. However, with the identification of the Tol pathway in Drosophila, the view on innate 
immunity changed. Until now, eleven homologues of the Drosophila Tol have been identified 
in mammals. They build up the so-caled Tol-like receptor (TLR) superfamily101. Al members 
of the  superfamily  harbor a  conserved  cytosolic  TIR (tol/interleukin-1 receptor)  domain, 
which is responsible for the binding  of respective  adaptor  proteins like  TRIF (TIR-domain-
containing adapter-inducing interferon-β) or Myd88 (Myeloid diferentiation primary response 
gene 88), which are necessary for further signal transduction102,103, finaly resulting in target 
gene  expression. In the folowing  section, the  signal transduction  of the  TLR3 receptor is 
described exemplarily, as the stimulation of this specific receptor holds also the possibility for 
cel death induction and Ripoptosome recruitment. 
After the binding of double-stranded viral RNA to the endosomal TLR3104, TRIF is recruited to 
the  cytosolic  part  of the receptor  via its  TIR  domain. From this  starting  point, a  variety  of 
celular  signals  can  be  switched  on.  TRIF  can  now  activate the IKK-related  kinases  TBK1 
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(TANK-binding kinase 1) and IKK-!105. They, in turn, phosphorylate TRIF itself, thereby 
enabling the recruitment of the transcription factor IRF3106. The close proximity alows TBK1 
to phosphorylate IRF3, which can now, in its active state, enter the nucleus to induce the 
production of type I interferons105. 
 
 
*%+,-.#F#0$?@#-.5.N'(-#&%+813%8+"#
K06*3.)06'<! 'E! 01+! +<,'9'*).! >MQA! &+:+80'&! N6)! ,'3C.+! 90&)<,+,! /D7! 69! 6<,3:6<(! )! N)&6+05! 'E! 96(<).6<(!
8)014)59#!7E0+&!906*3.)06'<=!>QIG!69!C6<,6<(!0'!01+!:50'9'.6:!8)&0!'E!01+!&+:+80'&#!>169!+<)C.+9!01+!&+:&360*+<0!
'E! >TU$JIUU;[! )<,! 01+! 0&)<9:&6806'<! E):0'&! IQGA!01)0! &+93.09! 6<! 01+! 8&',3:06'<! 'E! IDG;g#! I<! ),,606'<=! >Q7GR! 69!
&+:&360+,=! .+),6<(! 0'! 01+! ):06N)06'<! 'E! DG;ST! 'N+&! )! >7T?;>7U$;>Q7GR! :'<0)6<6<(! :'*8.+@#! G6<).5=! 3<,+&!
:'<,606'<9! 41+&+! :I7%9! )&+! ,+8.+0+,=! QI%$! 0'(+01+&! 4601! :)98)9+;W=!G7//!)<,!:GMI%!E'&*9!01+! Q68'80'9'*+!
416:1!69!&+:&360+,!0'!)<,!6<0+&:'<<+:0+,!4601!01+!>MQA!&+:+80'&!C5!C6<,6<(!'E!QI%$!0'!>QIG!N6)!609!Q`IV!,'*)6<#!
>169!+<)C.+9!01+!Q68'80'9'*+!E'&!)8'80'06:!)<,!<+:&'80'06:!:+.!,+)01!+@+:306'<#!
Introduction 
14 
In  paralel, the stimulation  of the  TLR3 receptor  can induce the  activation  of  NF-κB. 
Therefore, TRAF6  can  be recruited  and  activated  via  TRIF.  This leads to the further 
recruitment of TAB2 and TAK1. The TRAF6-TAB2-TAK1 complex dissociates to the cytosol, 
where  TAK1  can  be  activated.  This  enables TAK1 to further  activate the IKK  complex for 
subsequent NF-κB activation107 (Figure 5). 
In the last years, it was also shown that TLR3 stimulation enables the induction of cel death, 
when  cIAPs  are  depleted100.  The loss  of  cIAPs  stabilizes  RIP1, which alows  now for the 
recruitment of the  main  components  of the  Ripoptosome (FADD,  caspase-8  and  cFLIP)100. 
RIP1 can then  bind  TRIF  via its  RHIM  domain, thereby recruiting the  Ripoptosome to the 
TLR3 receptor.  As  mentioned  above, the  Ripoptosome  can then  execute  apoptotic  or 
necroptotic cel death, based on the celular conditions (Figure 5). 
 
V.3. The balance between life and death – cel death signaling complexes 
induce the  production  of inflammatory factors  and  cytokines  via the 
transcription factor NF-κB 
 
The transcription factor  NF-κB   was  originaly identified  by  playing  a  central role in  B-cel 
specific  gene  expression108.  Further  studies  showed that  proteins  of the  NF-κB family  are 
expressed in  almost  al tissues  and  cels109. They  are responsible for the  expression  of 
specific genes,  particularly involved in inflammation, innate immune responses  or 
apoptosis110. To date, there are five known members of the NF-κB family: RelA (also known 
as  p65),  c-Rel,  RelB,  NF-κB1 (p105/  p50),  and  NF-κB2 (p100/  p52)111,112.  RelA,  c-Rel  and 
RelB  are transcriptionaly  active,  whereas  NF-κB1  and  NF-κB2  are transcribed  as inactive 
precursors  of  105  and  100  kDA113.  These  precursors  undergo  proteolytic  cleavage to form 
the  active  NF-κB  p50/p52  proteins114,  which in turn form  homo- or  heterodimers  with  Rel 
proteins. In the inactive state, NF-κB homo- or heterodimers, stay associated with proteins of 
the IκB (nuclear factor of kappa light polypeptide gene enhancer in B-cels inhibitor) family, 
which are able to bind to the nuclear localization sequence (NLS) of NF-κB, thereby inhibiting 
their  nuclear translocation115.  The  most important IκB family  members  are IκB-β, IκB-ε  and 
the prototypical IκB-α112. As mentioned above, stimulation of death receptors, as exemplified 
for  TNF  or  CD95L,  or the  activation  of the  TLR3 receptor  can result in the  expression  of 
inflammatory  genes  after  NF-κB  activation73,90,107,116,117. Therefore,  cel  death  pathways  and 
NF-κB activation are closely connected. The activation of NF-κB is divided into two signaling 
pathways, namely the canonical (classical) and the non-canonical NF-κB pathway118. 
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V.3.1. The canonical NF-κB pathway 
The induction  of the  canonical  NF-κB  pathway responds to  a  variety  of  stimuli like  antigen 
binding, cytokine recognition or patern recognition. Al signals converge in the activation of 
the so caled IKK complex. This complex consists of the catalytic IκB kinases IKK-α and IKK-
β119,  as  wel  as  of the regulatory  subunit IKK-γ (also  caled  NEMO)120.  The  activated IKK 
complex  phosphorylates the inhibitory IκB-α, thereby triggering its  ubiquitination  and 
proteasomal  degradation121.  This, in turn, enables the  NF-κB  proteins to  enter the  nucleus 
and to activate their specific target  genes (Figure  2,  3  and  5). In terms  of the  canonical 
signaling  pathway  activation  of  RelA/p50  and  c-Rel/p50 NF-κB  complexes is  predominantly 
responsible for the gene inductive properties122. 
 
V.3.2. The non-canonical NF-κB pathway 
In contrast to the canonical NF-κB activation, the non-canonical signaling pathway relies on 
the  stabilization  of  NIK (NF-κB inducing  kinase).  Under  unstimulated  conditions,  cIAP 
proteins  are  constantly  marking  NIK for  proteasomal  degradation  via  ubiquitination123.  After 
the depletion of the celular cIAP pool, NIK is stabilized and forming a complex with IKK-α124, 
p100  and  RelB125.  Within this  complex, p100 is  phosphorylated  enabling the  proteolytic 
cleavage into the active p52 fragment126,127. The active p52/RelB heterodimer can than enter 
the nucleus to induce specific target genes. 
 
V.3.3. The non-canonical IKKs 
Whenever it comes to viral or bacterial infections, the innate immune system is the first line 
of celular defense mechanisms. The mentioned pathogens are detected as `` non-self`` by a 
variety of cytosolic or membrane bound receptors, like RIG-I (retinoid acid-inducible gene)128 
or the Tol-like receptor (TLR) family104. The outcome of the receptor stimulation is the above-
mentioned induction  of  NF-κB  and the  activation  of interferon (IFN) regulatory factors 
(IRFs)129,130.  These IRFs together  with  NF-κB  control the  expression  of immune regulatory 
genes, like interferons and cytokines130. In addition to the above-mentioned IκB kinases, the 
two IKK-related  kinases  TBK1 (TANK-binding  kinase  1)131 and IKK-ε (Inhibitor  of  nuclear 
factor kappa-B kinase subunit epsilon)132 were identified as important regulators, not only of 
the  described  NF-κB  pathway,  but  also for the  activation  of IRFs133.  TBK1  and IKK-ε  were 
termed the non-canonical IKKs, as they share large sequence similarity to the classical IKKs 
and are able to phosphorylate IκB-α134. 
Importantly, in  contrast to the  classical IKKs, TBK  and IKK-ε lack  a NEMO  binding  domain 
(NBD). Instead, they form similar signaling complexes with other scafold proteins, involved 
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in a variety of intracelular signaling pathways135. In terms of pathogen recognition, both 
proteins contribute to the activation of the transcription factors IRF3 and IRF7136, which in 
turn, induce the production of type I interferons. Moreover, the lack of TBK1 leads to 
embryonic lethality, due to TNF induced liver degeneration137. This shows that TBK1 is 
indispensable for NF-"B regulation  and interferon production during development. In 
contrast, IKK-! knockout mice are viable138. However, to date it is not clearly understood 
what the distinct roles of TBK1 and IKK-! are in IRF activation. Recent studies showed that 
the lack of TBK1 is reducing the IRF3 phosphorylation upon stimulation. In contrast, 
depletion of IKK-! does not alter the IRF3 activation. But the lack of both proteins abolishes 
the IRF3 phosphorylation and interferon production completely139. Meaning that in this 
situation, IKK-! can somehow compensate for the loss of TBK1, although the exact 
mechanism is stil unclear. Both proteins are composed of a kinase domain (KD) that houses 
its catalytic activity and three accessory regulatory elements: a ubiquitin-like domain (ULD), a 
Lysine-zipper (LZ) and a helix-loop-helix domain for protein interactions138 (Figure 6). TBK1 
is expressed in nearly al cel types, whereas IKK-! is only found in certain tissues. The IKK-! 
expression can be induced after pathogen infection. Thus, IKK-! is also caled the inducible 
I"B kinase140. 
Additionaly, further studies displayed an important involvement of TBK1 in autophagic 
execution. Here, TBK1 is responsible for the phosphorylation of the autophagy adaptor 
sequestosome-1 (also  p62 or SQSTM1) and optineurin (OPTN), which is important for 
autophagic clearance141. Moreover, recent studies showed that TBK1 is especialy involved 
in the process of mitophagy142, where damaged detrimental mitochondria are marked for 
degradation. The proteins PINK (PTEN-induced putative kinase 1) and Parkin are 
responsible for the addition of ubiquitin chains to the damaged mitochondria. These chains 
provoke the association of autophagy receptors like sequestosome-1 and TBK1 to associate 
with the mitochondria, enabling the activation of these adaptors and mitophagic clearance143. 
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VI. Aims of the Thesis 
 
During the last  decade, the identification  of the  Ripoptosome  and its  main  components 
enabled  a  novel  possible target for the treatment  of  various  diseases, including  cancer. 
Several  studies  showed that  genotoxic  stress  and the  depletion  of cIAPs triggered the 
formation  of the  2  MDa  Ripoptosome,  containing the  proteins  RIP1,  FADD,  caspase-8  and 
cFLIP99,144.  The formation  of this complex  can  either lead to  apoptotic  or  necroptotic  cel 
execution  based  on the  stoichiometric  composition.  During the last  years,  chemical 
compounds, so caled Smac mimetics were developed in order to deplete celular IAP levels. 
Indeed,  several  cancer identities  have  been  shown to  undergo  celular  execution  due to 
Ripoptosome formation  when treated  with  Smac  mimetics.  This  was for  example true for 
glioma145, lung  cancer146 or  acute lymphoblastic leukemia (ALL)  and promoted these drugs 
for clinical trials. In contrast, other cancer identities, like chronic lymphocytic leukemia (CLL), 
were quite resistant to the Smac  mimetic treatment  due to their inability to form  a 
Ripoptosome147.  These  studies  highlighted the importance for  a  beter  understanding  of 
Ripoptosome regulation  and formation in cancer treatment,  especialy to  overcome  other 
drug resistances.  
However, to date it is stil not fuly verified, if the core components RIP1, FADD, caspase-8 
and cFLIP do interact with other proteins to propagate Ripoptosome-mediated cel death or 
alternative signaling pathways. To generate deeper insight into the molecular mechanisms of 
Ripoptosome signaling, the folowing questions should be addressed in this thesis:  
 
• Are there  other integral  components  or  proteins interacting  with the 
Ripoptosome, besides RIP1, FADD, caspase-8 and cFLIP? 
 
• How  do  potentialy  novel  components  of the  Ripoptosome influence the  cel 
death machinery or other non-cel death related signaling pathways? 
 
By the use of mass spectrometric analysis, novel components of the Ripoptosome should be 
identified.  Based  on these results, the  appearances  and the function  of these  proteins  and 
their  postranslational  modifications in the  complex wil  be examined.  Thereby, their role in 
cel  death regulation or  non-cel  death  signaling pathways should  be dissected. Moreover, 
with the help of genetic manipulation, such as overexpression, knockdown or knockout of the 
respective  proteins, the role of the  Ripoptosome-associated  proteins wil be identified for 
TLR3-related and DL-mediated signaling pathways. 
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VI. Material and Methods 
 
VI.1. Material 
 
Table	1	Reagents	and	kits	
Reagents	and	kits	 Company	 Cat.	No.	
4-(2-Aminoethyl)-benzenesulfonyl	Fluoride	(AEBSF)	
Hydrochloride	
AppliChem	 A1421	
Agarose	Neo	ultra-quality	 Roth	 2267.2	
Ampicilin	sodium	salt	 Roth	 K029.1	
Aprotinin	 Roth	 A162.3	
BbsI	 New	England	BioLabs	 R0539S	
BD	OptEIA™	Human	IL-8	Set	 BD	Biosciences	 555244	
BD	OptEIA™	Reagent	Set	B	 BD	Biosciences	 550534	
Benzamidine	 Sigma-Aldrich	 12072-10G	
Bis-Tris	 Applichem	 A1025,0500	
Bovine	Serum	Albumin	(BSA)	 Santa	Cruz	 sc	2323A	
Bromophenol	blue	 Sigma-Aldrich	 B8026	
Calcium	chloride	dihydrate	 Sigma-Aldrich	 C3306	
Coloidal	Blue	Staining	Kit	 Thermo	Scientific		 LC6025	
cOmplete	Protease	Inhibitor	Cocktail	Tablets	 Sigma-Aldrich	 11836145001	
Crystal	violet	 Applichem	 A0691.0250	
di-Sodium	hydrogen	phosphate	dihydrate	 Roth	 4984.1	
dNTPs		 Thermo	Scientific		 R0193	
1,4-Dithiothreitol	(DTT)	 Applichem	 A2948.0025	
E.Z.N.A.	FastFilter	Plasmid	Maxi	Kit	 OMEGA	 D6924-04	
E.Z.N.A.	Gel	Extraction	Kit		 OMEGA	 D2500-02	
Ethanol	denatured	 Roth	 K928.4	
Ethanol	ROTIPURAN	 Roth	 9065.3	
GeneJET	Plasmid	Miniprep	Kit		 Thermo	Scientific	 K0503	
GeneRuler	1	kb	DNA	Ladder	 Thermo	Scientific	 SM0312	
GeneRuler	100bp	DNA	Ladder	 Thermo	Scientific	 SM0242	
Glycerin	ROTIPURAN	 Roth	 3783.2	
iBlot	2	Transfer	Stacks	 Life	technologies	 IB24001	
KAPA	SYBR	FAST	Universal	 Peqlab	 07-KK4600-03	
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LB-Agar	(Lennox)	 Roth	 X965.2	
LB-Medium	(Lennox)	 Roth	 X964.2	
Leupeptin		 Sigma-Aldrich	 L2884	
Luminata	Forte	Western	HRP	substrate	 Merck	Milipore	 WBLUF0500	
Methanol	AnalaR	NORMAPUR		 VWR	 20847.360	
Microlance	3	27	G	¾’	 BD	 302200	
MOPS	for	bufer	solutions	 AppliChem		 A1076,1000	
Nancy-520	 Sigma-Aldrich	 01494	
NuPAGE	Novex	4-12%	Bis-Tris	Protein	Gels	 Invitrogen	 NP0329BOX	
Pacific	Blue	Annexin	V	 Biolegend	 640918	
PageRuler	Prestained	Protein	Ladder	 Life	technologies	 26617	
Phusion	High-Fidelity	DNA	Polymerase	 New	England	BioLabs	 M0530L	
Pierce	ECL	Western	Blotting	Substrate	 Thermo	Scientific	 32106	
Potassium	chloride	 Roth	 6781.3	
Potassium	dihydrogen	phosphate	 Roth	 3904.1	
Protein	Assay	Reagent	A	 Bio-Rad	 5000113	
Protein	Assay	Reagent	B	 Bio-Rad	 5000114	
Protein	Assay	Reagent	S	 Bio-Rad	 5000115	
Protein	G	Agarose	 Roche	 05015952001	
Restore	Western	Blot	Stripping	Bufer	 Thermo	Scientific	 21063	
RNaseOUT	Recombinant	Ribonuclease	Inhibitor	 Invitrogen	 10777-019	
RNeasy	Mini	Kit		 Qiagen	 74106	
SDS	Pelets	 Roth	 CN30.3	
Skim	Milk	Powder	 Sigma-Aldrich	 70166-500G	
Sodium	chloride	(NaCl)	 Roth	 3957.2	
Sodium	citrate	dihydrate	 Sigma-Aldrich	 W302600	
Sodium	hydroxide	(NaOH)	solution	 Roth	 KK71.1	
Sodium	orthovanadate	 Sigma-Aldrich	 S6508	
SuperScript	I	Reverse	Transcriptase	 Invitrogen	 18064-071	
T4	DNA	Ligase		 Thermo	Scientific		 EL0016	
Tris	ultrapure	 AppliChem	 A1086,1000	
Triton	X-100	 AppliChem	 A1388,0500	
Tween	20		 Roth	 9127.3	
UltraPure	DNase/RNase-Free	Distiled	Water	 Invitrogen	 10977-049	
β-Glycerophosphate	disodium	salt	hydrate	 Sigma-Aldrich	 G9422-10G	
β-Mercaptoethanol	 Merck	Milipore	 805740	
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Table	2	Cel	culture	reagents	
Cel	culture	reagents	 Company	 Cat.	No.	
(Z)-4-Hydroxytamoxifen	 Sigma-Aldrich	 H7904	
AlStars	Negative	Control	siRNA	 Qiagen	 1027281	
Dimethyl	sulfoxide	(DMSO)	 AppliChem		 A3672,0100	
DMEM,	high	glucose,	GlutaMAX	 Thermo	Scientific	 61965-059	
DPBS,	calcium,	magnesium	 Thermo	Scientific	 14040-174	
EDTA	(Versen)	 Merck	Milipore	 L	2113	
Fetal	Bovine	Serum	(FBS)	 Thermo	Scientific	 10270-106	
Hepes	solution	 Sigma-Aldrich	 H0887	
Hygromycin	B	 A&E	Scientific	 P21-014	
Lipofectamine	2000	Transfection	Reagent	 Invitrogen	 11668-019	
Necrostatin-1	 Sigma-Aldrich	 N9037-25MG	
Opti-MEM	I	Reduced	Serum	Medium	 Thermo	Scientific	 31985-047	
Polyinosinic–polycytidylic	acid	sodium	salt	(poly	(I:C)	 Sigma-Aldrich	 P1530	
Polyprene	(Hexadimethrine	bromide)	 Sigma-Aldrich	 H9268-5G	
Puromycin	Dihydrochloride	 Thermo	Scientific	 A11138-03	
RPMI	1640	Medium	 Thermo	Scientific	 21875-091	
Sodium	Pyruvate	 Thermo	Scientific	 11360-088	
Sterile	Celulose	Nitrate	Membranes	 GE	Healthcare	 10401170	
Trypsin	2,5%	 Invitrogen	 15090-046	
Zeocin	Selection	Reagent	 Thermo	Scientific	 R250-01	
z-Val-Ala-DL-Asp-fluoromethylketone	(zVAD-fmk)	 Bachem	 N15100025	
	
	
	
Table	3	Cytokines	
Stimulatory	cytokines	 Source	
His-Flag-TNF	(TNF-HF)	 P.	Diessenbacher	116	
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Table	4	Antibodies	
Target	 	 Species/Feature	Application	 Company/Source	 Cat.	No.	
Primary	Antibodies	 	 	 	 	
Actin	(A2103)	 Rabbit	 WB	 Sigma-Aldrich	 A2103	
Caspase-8	(C15)	 Mouse	IgG2b	 WB	 P.H.	Krammer	 	
Caspase-8	(C20)	 Goat	 IP	 Santa	Cruz	 sc-6136	
cFLIP	(NF6)	 Mouse	IgG1	 WB	 Enzo	Life	Science	 ALX-804-961-01	
FADD	(1)	 Mouse	IgG1	 WB	 BD	Biosciences	 F36620	
Phospho-IRF3	(S396)	(D4G4)	 Rabbit	 WB	 Cel	Signaling		 4947	
IκBα	(C21)	 Rabbit	 WB	 Santa	Cruz	 sc-371	
Phospho-IκBα	(S32/36)	(5A5)	 Rabbit	 WB	 Cel	Signaling	 9246	
IKKε	(D20G4)	 Rabbit	 WB	 Cel	Signaling	 2905	
Phospho-IKKε	(S172)	(D1B7)	 Rabbit	 WB	 Cel	Signaling	 8766	
MLKL	(3H1)	 Rat	 WB	 James	Murphy	 	
Phospho-MLKL	(S358)		 Rabbit	 WB	 Abcam	 ab187091	
Phospho-p65	(Ser536)	(93H1)		Rabbit	 WB	 Cel	Signaling	 3033	
NF-κB2	p100/p52	 Rabbit	 WB	 Cel	Signaling	 4882	
RIPK1	(38)	 Mouse	IgG2a	 WB	 BD	Biosciences	 R41220	
Phospho-RIPK1	(S166)	 Rabbit	 WB	 P.	Gough	 	
RIPK3	 Rabbit	 WB	 Imgenex	 IMG-5846A	
TRADD	(37)	 Mouse	IgG1	 WB	 BD	Biosciences	 T610573	
TRAF2	(EPR6048)	 Rabbit	 WB	 Abcam	 ab126758	
β-Tubulin	(TUB	2.1)	 Mouse	IgG1	 WB	 Sigma-Aldrich	 T4026	
	 	 	 	 	
Secondary	antibodies	 	 	 	 	
Mouse	IgG1	 Goat/HRP	 WB	 SouthernBiotech	 1070-05	
Mouse	IgG2a	 Goat/HRP	 WB	 SouthernBiotech	 1080-05	
Mouse	IgG2b	 Goat/HRP	 WB	 SouthernBiotech	 1090-05	
Rabbit	 Goat/HRP	 WB	 SouthernBiotech	 4030-05	
Rat	 Goat/HRP	 WB	 SouthernBiotech	 3030-05	
Goat	IgG	 Rabbit/HRP	 WB	 SouthernBiotech	 6160-05	
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Table	5	Bufer	and	solutions	
Bufer/Solution	 Content	
DISC-lysis	bufer	 30	mM	TRIS-HCl	(pH	7.5)	
120	mM	NaCl	
10%	(v/v)	Glycerol,	
1%	(v/v)	Triton	X-100	
2	tablets	cOmplete	Protease	Inhibitor/100	ml	
	
Phospho-lysis	bufer	 20	mM	Tris-HCL	(pH	7,4)	
137	mM	NaCl	
10%	(v/v)	Glycerol,	
1%	(v/v)	Triton	X-100	
2	mM	EDTA	
50	mM	β-Glycerophosphate-disodium-salt-hydrate	
1	mM	Na-orthovanadate	
1	mM	AEBSF	Hydrochloride	
5	μg/ml	Aprotinin	
5	μg/ml	Leupeptin	
5	mM	Benzamidine	
	
5x	Laemmli	bufer	 250	mM	Tris-HCl	(pH	6.8)	
10%	(w/v)	SDS	
50%	(v/v)	Glycerol	
0.1%	(w/v)	Bromophenol	blue	
	
2x	HBS	bufer	pH	7.0	 280	mM	NaCl	
50	mM	Hepes	
1.5	mM	Na2HPO4	
	
Crystal	violet	dye	 0.5%	(w/v)	crystal	violet	
20%	(v/v)	methanol	
	
TAE	bufer		 40	mM	Tris	
20	mM	acetic	acid	
1	mM	EDTA	
 
PBS	(pH	7.4)	
	
2.7	mM	KCl	
1.5	mM	KH2PO4	
137	mM	NaCl	
8	mM	Na2HPO4	
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Table	6	Software	
Software	 Source	
Image	J	 National	Institute	of	Health	(NIH)	
MaxQuant	(version	1.5.2.8)	 coxdox.org	
MxPro	QPCR	Software	 Agilent	
Primer3	 Whitehead	Institute	for	Biomedical	Research	
Walac	1420	WorkOut	Data	Analysis	software	 PerkinElmer	
 
Table	7	Devices	
Device	 Company	
Curix	60	 AGFA	
EASY-nLC	1000	 Thermo	Scientific	
Gel	iX20	Imager	 INTAS	
Mx3005P	QPCR	System	 Agilent	
NanoDrop	2000	Spectrophotometer	 Thermo	Scientific	
Q	Exactive	Plus	 Thermo	Scientific	
T100	Thermal	Cycler	 BioRad	
VICTOR3	1420	Multilabel	Reader	 PerkinElmer	
 
VI.2. Methods 
 
VI.2.1. Cel culture 
 
Table	8	Cel	lines	
Cel	line	 Origin	
HaCaT	 Keratinocytes	
HeLa	 Cervical	carcinoma	
Jurkat	 T-Lymphocytes	
HEK293T	 Embryonic	kidney	cels	
 
Cel lines used in this study (Table 8) were cultured at 37°C under 5% CO2. Jurkat cels were 
cultured in RPMI 1640 medium containing 10% heat inactivated fetal calf serum (FCS). This 
suspension cel line was split when a confluence of 1x 106 cels/ml was reached. Therefore, 
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cels were sedimented by centrifugation at 400x g for 5 min folowed by resuspension in fresh 
medium and dilution with a maximum ratio of 1:10, depending on the period of cultivation. Al 
other  cel lines  were  cultured in  DMEM  medium (Dulbecco´s  Modified  Eagle  Medium) 
containing  4,500  mg/l  glucose  and  4  mM  L-glutamine,  additionaly  supplemented  with  1% 
Hepes,  1%  sodium  pyruvate  and  10%  FCS.  The adherent  cel lines  were  split  when they 
reached  a  confluence  of  80-100%.  Therefore, cels  were  washed  with  DPBS folowed  by 
detachment  via  2.5%  Trypsin  solution.  Trypsinisation  was  stopped  by addition  of  DMEM 
containing  10%  FCS.  Cels  were resuspended until a  homogenous  cel  suspension  was 
reached.  The  cels  were  sedimented  by  centrifugation  with  400x  g for  5  min  at room 
temperature (RT). After removal of the supernatant, the cel pelet was resuspended in fresh 
medium and diluted depending on the period of cultivation. HaCaT cels were diluted with a 
maximum ratio of 1:5, whereas HeLa and HEK293T cels were diluted with a ratio up to 1:15. 
 
VI.2.2. SDS-PAGE and Immunobloting 
For the  creation  of  celular  protein lysates,  cels  were  washed  with  DPBS folowed  by 
extraction  with  DISC-lysis  bufer.  Therefore, cels  were lysed for  45  min  on ice.  The  cel 
extracts were centrifuged for 30 min with 20,000x g at 4°C to sediment celular debris. The 
protein  concentration  was  determined  using the  DCTM Protein  Assay (BioRad)  according to 
manufacturer´s instructions. Protein  samples  were  prepared  under reducing  conditions  by 
the addition of Laemmli bufer and 5% 1 M DTT. Lysates were diluted to a final concentration 
of  0.5-1  µg/µl, folowed  by  boiling  at  96°C for  10  min.  Samples  were finaly loaded  on 
NuPAGE  4-12%  BisTris  gels (Invitrogen)  and  proteins  were  separated in  MOPS  bufer 
according to  manufacturer´s  protocol.  Additionaly,  PageRuler  Prestained  Protein  Ladder 
(Life  Technologies)  was loaded  on  each  gel to  visualize the molecular  weight  and  protein 
separation. 
For  Western  Blot  analysis, separated  proteins  were transferred to  polyvinylidene  difluoride 
(PVDF)  membranes  using the iBlot2  Transfer  Stacks (Life  Technologies)  according to 
manufacturer´s instructions.  After  blotting,  membranes  were  blocked  with  5% non-fat  dried 
milk in  PBS  plus  0.1%  Tween20 (from  here  on referred  as  PBST) for  1  h  at  RT.  Primary 
antibodies were diluted in 5% milk in PBST or 5% BSA (bovine serum albumin) in PBST with 
the respective concentrations. Membranes were incubated with the primary antibodies on a 
rocker  shaker  overnight  at  4°C.  Membranes  were  brought to  RT  and  washed four times in 
PBST.  The respective  secondary  antibodies  were  diluted  1:10000 in  5%  milk in  PBST  and 
incubated with the membranes for 1 h at RT. Membranes were washed three times in PBST 
and once in PBS only. Protein signals were visualized depending on their respective strength 
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using Pierce ECL Western Bloting substrate (Thermo Scientific) or Luminata Forte Western 
blot HRP (Millipore) and the Curix 60 (AGFA) developing machine. 
 
VI.2.3. Detection of Phosphoproteins 
Cels were stimulated and harvested as described before. To visualize protein modifications, 
especialy  phosphorylation  of  serine residues,  cels  were  quickly  homogenized  by pushing 
the cel pelet three times through a 0.4 mm Microlance needle (BD). This was performed in 
the special Phopho-lysis bufer, containing diferent phosphatase inhibitors. 
 
VI.2.4. Transfection and Transduction 
In order to reach an optimal transfection and transduction eficiency, cels were seeded at the 
respective concentrations to receive  a  confluence  of 60-70%  at the  day  of transfection  or 
transduction. 
 
VI.2.4.1. siRNA-mediated knockdown 
For transient knockdown experiments, the folowing siRNA duplexes were used: 
• Dharmacon siGenome set of 4 human TBK1 siRNA (Cat. No.: MU-003788-02-0002)  
• Dharmacon siGenome set of 4 human IKBKE siRNA (Cat. No.: MU-003723-02-0002) 
• Quiagen AlStars Negative Control siRNA (Cat. No.: 1027281) 
• FlexiTube Gene Solution for TRAF2 (Cat. No.: GS7186) 
For siRNA  mediated  gene  knockdown, 2x 105 cels  were  seeded  per  wel of  a  6-wel  plate, 
one day prior to the planned transfection. The next day, 5 µl Lipofectamine 2000 was added 
to  300 µl  Opti-MEM  medium and incubated  10  min  at  RT. In  a  separate tube, 5 µl  of the 
respective 10 µM siRNA stock solution was mixed with 300 µl Opti-MEM. The two solutions 
were  combined  and incubated for  20  min  at  RT, in  order to  alow for  siRNA/Lipofectamin 
complex formation.  Meanwhile, the  old  medium  was  discarded from the  cels  and  1.4  ml 
fresh  Opti-MEM  medium  was  added.  Finaly, the transfection  mixture  containing the  siRNA 
was  added  dropwise to the  cels.  Knockdown  was  monitored  72  h  after transfection  by 
Western Blot analysis. 
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VI.2.4.2. Generation of lentiviral particles 
For the generation of lentiviral particles,  HEK293T cels were cultured in 10 cm dishes and 
grown to  60-70%  confluence.  The  cels  were transfected  using  calcium  phosphate 
transfection  and the  2nd generation  packaging  system.  Therefore,  3 µg  pMD2.G,  7.5 µg 
pSPax2, and 3 µg pcDNA3.1/p35 of lentiviral packaging vectors were co-transfected together 
with  10 µg  of the transfer  vector.  The transfer  plasmid  was  either  pF  Super  PGK  Hygro 
(Gev16)  providing the  4-HT-dependent  expression  of  Gal4  or  pF  5x  UAC  MCS  W  SV40 
containing the cDNA sequence of interest95,116. This inducible transfer plasmid expresses the 
gene  of interest in  a  Gal4-dependent fashion.  For the  calcium  phosphate transfection, 
medium was removed from the cels and 6 ml fresh medium containing 25 µM chloroquine 
was  added, folowed  by  2  h incubation at  37°C.  Meanwhile, the  above-mentioned  plasmid 
DNA was diluted in a total volume of 500 µl containing 250 mM CaCl2. Additionaly, 500 µl 2x 
HBS  bufer  were  prepared in  a  separate tube. In  order to increase the  surface  and the 
oxygen uptake, air bubbles were carefuly created in the HBS bufer by constant airflow from 
a  pipete  controler.  The  DNA  CaCl2 solution  was  carefuly  added  dropwise into the  air 
bubbled HBS bufer. The combined solution was incubated for 25 min at RT. The transfection 
solution was added dropwise to the cels and they were incubated overnight at 37°C. On the 
next day, medium containing the retroviral particles was colected, filtered (0.45 µm), shock 
frozen in liquid nitrogen, and finaly stored at -80°C. Again, 6 ml fresh medium was added to 
the  cels for  a  second  colection  of  viral  supernatants  on the folowing  day.  Al  steps 
described were carried out according to the safety class two requirements. 
 
VI.2.4.3. Generation of stable cel lines 
For the generation of stable cel lines, the above-described viral particles were thawed and 5 
µg/ml polybrene  was  added.  The  viral  polybrene  solution  was  added to  cels, folowed  by 
spin-infection (2300 rpm) for 1.5 h at 30°C. The day after, cels were washed three times with 
PBS  and reincubated  with fresh  DMEM  at  37°C.  On the  second  day  after transfection, 
successfuly transduced  cels  were  selected  using the respective  antibiotic resistance 
harbored  by the transduced  plasmid.  Therefore,  cels  were  cultured in  medium  containing 
1µg/ml  Puromycin (pF  5x  UAC  MCS  W  SV40)  or  300 µg/ml  Hygromycin (pF  Super  PGK 
Hygro (Gev16)).  Selection  was  completed,  when  100%  of  untransduced  control  cels  were 
kiled, which was normaly the case in 4-10 days. Al steps were carried out according to the 
safety  class two requirements  until the  cels  were  washed  at least  six times in  virus free 
medium after transduction. 
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VI.2.5. Agarose gel-electrophoresis and gel-extraction 
For the visualization of plasmid DNA or DNA fragments, agarose based gel-electrophoresis 
was  used.  Therefore,  1%  agarose  gels,  containing  0.5x  Nancy-520 (Sigma-Aldrich)  were 
prepared from TAE bufer and low melt agarose (Roth). DNA samples were separated using 
electrophoresis and visualized by UV light. Successfuly digested vector fragments were cut 
out from the gel and purified using the E.Z.N.A. Gel Extraction Kit (Omega). Purification was 
carried out according to manufacturer´s instructions and final DNA fragments were eluted in 
DNase free  water.  DNA  quality  and  concentration  were measured  using  a  NanoDrop  2000 
spectrophotometer. 
 
VI.2.6. CRISPR/Cas9-mediated knockout of target genes 
 
VI.2.6.1. Primer design and annealing for gRNA insert preparation 
CRISPR gRNA sequences were generated using the open access software provided on the 
htp:/crispr.mit.edu/ webpage. For the design of the forward primer, a G was added in front 
of the  20  bp (base  pair)  gRNA  sequence.  The  sequence including the  G was  used for the 
reverse  complement  building the reverse  primer.  Additionaly,  a  CACC  overhang for  BbsI 
recognition  was  added in front  of the  G for the forward  primer.  AAAC  was  added  as  BbsI 
recognition site on the reverse primer.  
Table	9	Primer	for	CRISPR	gRNA	ligation	with	BbsI	sites	
Primer	 forward	 reverse	
TBK1	gRNA	#1	 CACCGGCTACTGCAAATGTCTTTCG	 AAACCGAAAGACATTTGCAGTAGCC	
TBK1	gRNA	#2	 CACCGTTTGAACATCCACTGGACGA	 AAACTCGTCCAGTGGATGTTCAAAC	
IKK-ε	gRNA	#1	 CACCGGTTGCGGGCCTTGTACACAC	 AAACGTGTGTACAAGGCCCGCAACC	
IKK-ε	gRNA	#2	 CACCGCATTGTCAAGCTCTTTGCGG	 AAACCCGCAAAGAGCTTGACAATGC	
TRAF2	gRNA	#1	 CACCGATATATGCCCTCGTGAACAC	 AAACGTGTTCACGAGGGCATATATC	
TRAF2	gRNA	#2	 CACCGGCAGCTAGCGTGACCCCCCC	 AAACGGGGGGGTCACGCTAGCTGCC	
 
The forward and reverse primer (100µM) were mixed in a 1:1 ratio. For annealing of the two 
oligos, the  mixture  was  boiled  at  100°C for  5  min, folowed  by  cooling  down  at  RT.  The 
annealed oligos were diluted 1:300.  
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VI.2.6.2. Restriction enzymatic digestion 
The empty pSpCas9(BB)-2A-GFP (PX458) plasmid (Addgene, kindly provided by the lab of 
Prof.  Pascal  Meier, ICR  London,  UK)  was  digested  with the restriction  enzyme  BbsI (New 
England Biolabs) for cloning of the respective gRNA. Therefore, 1-2 µg of the plasmid was 
mixed with 1 µl of BbsI and 2 µl 10x NEB bufer 2. The volume was adjusted to a final volume 
of 20 µl. The reaction was performed for 2 h at 37°C. The digested vector was cleaned up via 
agarose gel electrophoresis and gel-extraction as described above. 
To combine the gRNA oligos and the digested plasmid, 10 µl ligation reaction was prepared 
for each gRNA. Therefore, 1 µl of the digested plasmid, 1 µl of the diluted gRNA Oligos, 1 µl 
T4 DNA ligase, and 1 µl ligation bufer (New England Biolabs) were incubated 3 h at RT. 
 
VI.2.6.3. Transformation and plasmid isolation 
The ligated plasmids were transformed into chemical competent TOP10F E. coli (Invitrogen) 
bacteria.  Therefore, the  whole  10 µl ligation  mixture  was  mixed  with  100 µl  bacteria  and 
incubated on ice for 30 min. Afterwards, cels were heat shocked shortly for 45 sec at 42°C, 
folowed by an additional incubation on ice for 2 min. 500 µl lysogeny broth (LB) medium was 
added to each sample, folowed by a gently shaking incubation for 1 h at 37 °C. Transformed 
bacteria were finaly plated on LB agar plates containing 100 µg/ml ampicilin and incubated 
overnight  at  37°C.  Single  colonies  were  picked  and transferred into  15  ml  Falcon reaction 
tubes  containing  approximately  3-5  ml  LB  medium  containing  100 µg/ml  ampicilin (LBAmp). 
The tubes were again gently shaking incubated overnight at 37°C. Plasmid DNA was isolated 
using the  GeneJET  Plasmid  Miniprep  Kit (Thermo  Scientific)  according to  manufacturer´s 
instructions.  The  constructs  were  verified  by  sequencing  and  succesfuly  generated 
plasmids  were  again transformed into  bacteria  as  described  above.  After  growing them  on 
LB  agar  plates,  single  colonies  were  picked  and inoculated in  sterile  Erlenmeyer flask 
containing  200  ml  LBAmp overnight  at  37°C.  Plasmids  were isolated  using the  E.Z.N.A 
Fastfilter Plasmid Maxi Kit (Omega) according to manufacturer´s instructions. Plasmids were 
eluted in 1.5 ml DNase free water and analyzed with a NanoDrop 2000 spectrophotometer. 
 
VI.2.6.4. CRISPR knockout of RIP1 
RIP1 deficient HeLa cels were generated using the CRISPR/Cas9 system. Therefore, 1x 105 
HeLa cels were seeded per wel in 6-wel plates. The next day, 600 ng pBluescript CRISPR 
plasmid,  containing the  gRNA targeting RIP1 (kindly  provided  by the lab  of  Prof.  Pascal 
Meier ICR  London,  UK)  and  1 µg  of the  Dharmacon  mKate-Cas9  Nuclease  expression 
plasmid were  co-transfected,  using  1 µl  Dharmafect  Duo  Transfection reagent  per  6-wel. 
The  RIP1 target  sequence is  shown in  Table  10.  Two  days  after transfection,  cels  were 
Material and Methods 
29 
sorted  via BD  FACSAria I (BD  Bioscience) for  mKate  expression  and  plated  as  single  cel 
clones in  96-wel  plates.  Arising  clones  were  cultured for  2-3  weeks  and  analyzed for 
successful RIP1 knockout by Western bloting. 
 
VI.2.6.5. CRISPR knockout of TBK1, IKK-ε and TRAF2 
For the  knockouts  of  TBK1, IKK-ε  and  TRAF2  second  generation  CRISPR  plasmids 
containing the  Cas9  nuclease  as  wel  as the  gRNA  were  used.  CRISPR  gRNA  sequences 
were  generated  using the  Zhang’s lab  open  access  gRNA  generation  software 
(htp:/crispr.mit.edu/).  The first  100  bp  of the target  gene  mRNA  were pasted into the 
software. Two CRISPR sequences were used for each gene to avoid of-target efects. 
 
Table	10	Sequences	of	the	single	CRISPR	gRNAs		
Primer	 forward	
TBK1	gRNA	#1	 GCTACTGCAAATGTCTTTCG	
TBK1	gRNA	#2	 TTTGAACATCCACTGGACGA	
IKK-ε	gRNA	#1	 GTTGCGGGCCTTGTACACAC	
IKK-ε	gRNA	#2	 CATTGTCAAGCTCTTTGCGG	
TRAF2	gRNA	#1	 ATATATGCCCTCGTGAACAC	
TRAF2	gRNA	#2	 GCAGCTAGCGTGACCCCCCC	
RIP1	gRNA	 TCGGGCGCCATGTAGTAG	
 
The identified target  sequences  were  cloned into the  pSpCas9(BB)-2A-GFP (PX458) 
plasmid, as described above. 1x 105 HeLa cels were seeded per wel in a 6-wel plate. The 
next  day, the  cels  were transfected  with  500  ng  pSpCas9(BB)-2A-GFP  containing the 
respective  gRNA,  using  5 µl  GeneJuice  Transfection reagent (Merck/Milipore).  Two  days 
after transfection,  cels  were separated via BD  FACSAria I (BD  Bioscience).  Single  cel 
clones  expressing  GFP  were  plated  as  single  cel  clones in  96-wel  plates.  Arising  clones 
were  cultured for  2-3  weeks  and  analyzed for a successful  knockout  of the target  gene  by 
Western bloting.  
 
VI.2.7. Gel-filtration 
The  described  gel-filtration  was  kindly  done by  our  cooperation  partner in  Leicester (Prof. 
Marion MacFarlane from the Molecular Mechanisms of Cel Death section, MRC Toxicology 
Unit) as described before148. In brief, HaCaT RIP1 WT cels (∼1x 108) were treated 6 h with 
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100  nM  4-HT to induce  Ripoptosome formation.  Thereafter, the cels  were lysed in  2  ml 
DISC-lysis bufer before being cleared by centrifugation. The cleared lysate was then loaded 
onto  an  agarose  matrix (Superrose  6)  and forced through the  column  using low  pressure. 
Smal fractions, containing size separated protein fractions, were colected and analyzed via 
Western Blot analysis. 
 
VI.2.8. Caspase-8 Immunoprecipitation (IP) 
The respective  cel lines  were  seeded in T175 flasks  and  grown to  80-90%  confluence (~ 
1.5x  107 cels).  After  appropriate  stimulation, the cels  were  washed  once  with  cold  PBS, 
folowing solubelization with 5 ml 2.5% Trypsin. Once the cels were detached, 5 ml of DMEM 
medium  with  10%  FCS  was  added in  order to  stop the trypsinization.  The  cel  suspension 
was  centrifuged  5  min  with  400x  g  and the  pelet  was resuspended in  PBS.  After  another 
round  of  centrifugation (5  min  at  400x  g),  cels  were lysed  on ice by the  addition  of  1.5  ml 
DISC-lysis bufer. After 45 min of lysis, the lysates were centrifuged at 20,000x g for 30 min, 
respectively, to remove celular debris. The protein concentration of the cleared lysates was 
determined by Bradford assay. A smal fraction of 100 µg from each lysate was used as an 
input control, named TL (total lysate). For the immunoprecipitation, 30 µl protein G-agarose 
beads and 1 µg caspase-8 antibody (C20) was added to 2 µg of the total protein lysates. Al 
samples  were incubated  overnight  on  an  overhead shaker  at  4°C.  The  next  day, the 
supernatants were discarded and the beads with the bound afinity precipitates were washed 
5x with 1 ml of DISC-lysis  bufer.  The  bound  proteins  were  eluted from the  dried  beads  by 
addition  of  standard reducing  sample  bufer  and  boiling for  10  min  at  95°C.  Subsequently, 
protein  samples  were  separated  by  SD-PAGE  on  4-12%  NuPAGE  gradient  gels  and 
precipitated proteins were visualized by Western Blot analysis. 
 
VI.2.9. Cel death analysis by crystal violet staining 
1-1.5x 104 cels of the diferent cel lines were seeded per wel in a 96-wel plate. The next 
day, the cels were stimulated in triplicates with the respective ligands and incubated for the 
appropriate time at 37°C. After the stimulation, the supernatant was discarded and the cels 
were carefuly washed two times with PBS to remove detached cels. 50 µl of crystal violet 
solution  was  added  per  wel, respectively.  The  plate  was incubated for  20  min  at room 
temperature  on  a  platform tumbling  shaker.  For removal  of the Crystal  violet,  cels  were 
washed  with tap  water until the  excessive  dye  was removed  completely.  The  stained  cels 
were  put  upside  down  on  a  paper towel  and  dried for  minimum  2  h  at  RT to  get rid  of 
remaining liquids. To dissolve the crystal violet dye, 200 µl Ethanol per wel was added and 
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the plate was incubated 20 min at RT on a platform tumbling shaker. Optical density of the 
single  wels  was  measured  with  a  VICTOR3  1420  Multilable  Reader  and  optical  density  of 
control  conditions (cels treated  with  diluents)  was  set to  100% to  alow  comparison.  For 
statistical  analysis,  mean  values  of three independent  experiments  were  assessed.  To 
accommodate  experimental  deviations, the  standard  error  of  mean (SEM)  was  calculated 
using Excel.  
 
VI.2.10. RNA Isolation 
For the isolation  of total  celular  RNA, the respective  cel  pelets  were treated  according to 
manufacturer´s instructions of the RNeasy Mini Kit (Quiagen). Therefore, cels were washed 
in PBS, folowed by lysis in RLT bufer containing 1% β-mercaptoethanol. RNA was extracted 
using spin column purification. The purified RNA was washed twice, folowed by elution with 
RNase free  water.  RNA  quality  and  concentration  was  measured  using  a  NanoDrop  2000 
spectrophotometer. For the reverse transcription reaction, 1.5 µg RNA of each sample was 
diluted in RNase free water to a final volume of 9.8 µl. The diluted RNA was mixed with 1 µl 
10 mM deoxynucleoside triphosphate (dNTP), 1 µl 100 µM random nanomers and 0.2 µl 100 
µM  oligo  dT  primer.  The  probes  were incubated in a thermocycler for  5  min  at  65°C. 
Afterwards, the samples were taken out from the thermocycler and 4 µl 5x First Bufer, 2 µl 
0.1  M  DTT,  0.5  µl  RNase  out (Life  Technologies),  and  0.5  µl  Superscript I (Life 
Technologies) was added into each reaction tube. The samples were further incubated in the 
thermocycler for 2 min at 42°C, 12 min at 25°C, 50 min at 42°C, and finaly 15 min at 70°C. 
The synthesized cDNA was finaly diluted to a concentration of 100 ng/µl. 
 
VI.2.11. Quantitative real time polymerase chain reaction (qPCR) 
For the  analysis  of  gene  expression  qPCR  analyses  were  performed.  Primer for the 
respective target genes were designed using the open source program Primer3. The Primers 
were diluted to a final concentration of 20 µM. Each single sample was prepared with a final 
volume of 20 µl, containing 8.8 µl cDNA (100 ng/µl), 10 µl. KAPA SYBR FAST (Peqlab), 0.4 
µl ROX (Peqlab), 0.4 µl forward and reverse primer. Single cDNAs or conditions were always 
analyzed in triplicates.  qPCR  analyses  were performed  using  a  Mx3005P  QPCR  System 
(Agilent). Equal cycling conditions were used to amplify the genes of interest.  
Melting curve analysis was used to confirm the specific amplification of single products of the 
expected size. Furthermore, al primers used for qPCR studies have been tested before by 
cDNA dilution curves to show eficiency within 80-110%. Al samples were tested to have a 
low variance in the housekeeping gene (GAPDH) expression, which was set as a calibrator 
in the  MxPro  software.  The relative fold induction was  determined  by  using the relative 
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quantification to the  calibrator (dRn),  calculated  by the  MxPro  software.  Unstimulated  Ctrl 
samples were set to 1 and the respective samples of interest were calculated by dividing the 
dRn values of interest through the value of the Ctrl sample. 
The qPCR program was set as folows: 
 
• 50°C for 2 min 
• 95°C for 10 min 
 
Folowed by 42 cycles of: 
 
• 95°C for 30 sec 
• 60°C for 1 min 
 
Ended with a final cycle of: 
 
• 95°C for 1 min 
• 65°C for 30 sec 
• 95°C for 1min  
 
VI.2.12. Microarray analysis 
For the analysis of gene expression profiles, 2x 105 HaCaT RIP1 WT cels were seeded per 
wel of a 6-wel plate. The next day, cels were transfected with Ctrl, TBK1 and IKK-ε siRNAs 
as  described  above.  Three  days  after transfection, cels were  starved for 3  h in  DMEM 
medium without FCS, folowed by stimulation with 50 µM Necrostatin-1 (Nec-1) for 1 h. RIP1 
expression was induced by the addition of 4-HT for 8 h. RNA was isolated, using the Qiagen 
RNeasy Mini Kit as described above. Gene expression of the single samples was analyzed 
by  microarray  analysis in three independent  biological replicates.  The  array  analysis  was 
kindly  done  by the lab  of  Martin  Sprick (DKFZ,  Heidelberg)  and the Genomics  and 
Proteomics Core Facility of the German Cancer Research Center (GPCF DKFZ, Heidelberg), 
as described in recent publications149. In brief, RNA (500 ng per sample) was labeled, using 
the Ilumina  TotalPrep  RNA  Amplification  Kit  according to the  manufacturer’s instructions. 
cRNA  was  hybridized to  human  whole-genome Ilumina  HumanHT-12  V4.0  expression 
BeadChip (Ilumina, Inc.). BeadChips were scanned with an Ilumina iScan system (Ilumina 
Inc.).  Scanning  and feature  extraction  was  performed  using  BeadScan  and  BeadStudio 
software (Ilumina)  with  standard  setings for the  chips  used.  Quantile  normalization  was 
performed with the Ilumina BeadStudio. 
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VI.2.13. SILAC labeling and mass spectrometry 
The SILAC in this study was kindly done by the group of Prof. Ivan Dikic from the Institute of 
Biochemistry I,  Goethe  University  Medical  School in  Frankfurt  as  described  before150. In 
brief,  HeLa  RIP1  WT  and  TBK/IKK-ε  KO  RIP1  WT  cels  were  grown in  medium  containing 
heavy (HeLa  WT)  or light (TBK/IKK-ε  KO) isotope labeled  amino  acids. Cels  were 
maintained in  custom-made  SILAC  DMEM (heavy/medium/light) for  10  days,  and 
incorporation  of labeled amino acids to more the 95% was verified. Celular lysates of both 
cel lines were generated and mixed in 1:1 ratio. Protein lysates were loaded onto a 4-12% 
gradient  SDS/PAGE  gel  and  proteins  were  stained  using the  Coloidal  Blue  Staining  Kit 
(Thermo Fisher) and digested in-gel, using trypsin. Peptides were extracted from the gel and 
desalted  on reversed  phase  C18  StageTips. Peptide fractions  were  analyzed  on  a 
quadrupole-Orbitrap mass spectrometer (Q Exactive Plus; Thermo Scientific) equipped with 
an ultrahigh-performance liquid chromatography (UHPLC) system (EASY-nLC 1000; Thermo 
Scientific). Raw data files were analyzed using MaxQuant (version 1.5.2.8) and compared for 
protein phosphosites. 
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VII. Results 
 
VII.1. Spontaneous  Ripoptosome formation  and  cel  death induction 
depends on intracelular RIP1 level 
 
Many studies have highlighted that RIP1 is one of the key players in celular PCD signaling 
pathways151–153. The dual function of RIP1 is reflected by the death receptor-mediated NF-κB 
activation, as described in detail for TNFR1, thereby promoting cel survival151,154. In contrast, 
RIP1 is one of the key mediators of the necroptotic signaling cascade, where it is responsible 
for the  activation  of  RIP340,47,56.  Moreover,  RIP1 is the  central  component  of the 
Ripoptosome,  whose formation  can lead to  apoptosis  as  wel  as  necroptosis95,99,100,144. 
Hence, the intracelular protein level and the activation of RIP1 have to be tightly regulated in 
order to maintain normal celular viability and function. 
 
VII.1.1. Expression of RIP1 induces kinase-dependent cel death in HaCaT and 
HeLa cels 
As  mentioned  above,  changes in the intracelular  RIP1 level  could  have  severe  efects  on 
celular signaling pathways and thereby cel viability. In order to investigate the role of RIP1 
for  cel  death regulation as  wel  as  cel  death-independent signaling pathways,  cel  models 
with a 4-Hydroxy-Tamoxifen (4-HT) inducible RIP1 expression were established. Therefore, 
HaCaT and  HeLa  cels  were transduced with recombinant lentiviral  particles, containing 
cDNAs specific for Gev16 and RIP1 WT as described in former publications95,116. The newly 
generated  cel lines  were  named HaCaT  RIP1  WT  and  HeLa  RIP1  WT. To  determine the 
optimal point of time for substantial RIP1 protein expression upon 100 nM 4-HT stimulation, a 
time-dependent  kinetic  was  performed (Figure  1A).  Substantial increase in  RIP1 level  was 
detected four hours after stimulation. The expression level of the kinase was comparable in 
both  cel lines. In  order to rule  out  side  efects  of the  4-HT  stimulation in respect to  PCD 
related  components,  Western  Blot  analyses  of the respective  proteins  were  performed. 
HaCaT  cels  showed  no  significant  changes in the  expression level  of the proteins  FADD, 
MLKL or RIP3 (Figure 1A). cFLIP was not shown as HaCaT cels harbor very low level of this 
protein, which  are  under the  detection limit  of the  used  antibody. In  contrast, caspase-8 
levels  were reduced  over time in line  with the  RIP1  expression,  most  probably  due to 
caspase-8  cleavage, indicating activation  and  cel  death induction. HeLa  cels  showed the 
cleavage  of  cFLIP in line  with the increasing  RIP1 level, indicating that increased  RIP1 
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activity leads to caspase-8 activation that finaly targets cFLIP (cleavage) and promotes the 
induction  of  cel  death (Figure  1C). Interestingly, the  caspase-8  protein level seems to  be 
rather  unchanged, indicating that the  cel  death induction is  weaker  when  compared to 
HaCaT cels. FADD and MLKL showed no significant diferences in their protein level upon 
RIP1 expression (Figure  1C).  RIP3  was  not  shown in  HeLa  cels  as these  cels  are  RIP3 
negative. 
The indicated induction of cel death by the observed reduction of caspase-8 level and cFLIP 
cleavage  was further functionaly  analyzed by  crystal  violet  staining.  This  assay  measures 
changes in  cel  atachment in respect to  certain  stimulations.  Therefore, this  assay can  be 
used as an indicator for cel death, although the observed diferences could also be due to 
growth inhibitory efects. In the folowing, the detected cel detachment was set equal to cel 
execution, although the described crystal violet assays do not measure cel death directly. In 
order to  distinguish  between  caspase-dependent (apoptotic)  and  caspase-independent 
(necroptotic)  cel  execution, both  cel lines  were  prestimulated  with the  caspase inhibitor 
carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone (zVAD-fmk)155–157 and the 
RIP1 kinase inhibitor  Necrostatin-1 (Nec-1)158.  RIP1  expression  was induced by  a  20-hour 
stimulation  with increasing  concentrations  of  4-HT (Figure  1B  and  1D). Both  cel lines 
showed substantial decrease in cel atachment, indicating an increased cel death response 
in line  with the  expression  of  RIP1 (Figure  1B  and  1D).  The  combination  of  zVAD-fmk  and 
Nec-1  completely  blocked cel  death  compared to the  unstimulated  control (Ctrl)  after the 
overexpression of RIP1. The addition of the RIP1 kinase inhibitor Nec-1 could only partialy 
(about  20%) rescue from  detachment. The  caspase inhibitor  zVAD-fmk  could  completely 
abrogate cel death in  HeLa  cels,  arguing for the  exclusive  appearance  of  apoptotic  cel 
death. This was expected, as these cels lack the necroptotic relevant RIP3. In contrast, the 
protection by zVAD-fmk in HaCaT cels reached only 80% (Figure 1B, red curve), indicating 
the  appearance  of  a  caspase-independent, potentialy  necroptotic  cel  death. In  general, 
HaCaT cels were more  sensitive to  cel  death (100% dead cels after 20 hours stimulation 
with 50 nM 4-HT) induced by RIP1 expression when compared to HeLa cels, which showed 
a maximum of 40% dead cels after 20 hours with 200 nM 4-HT. Altogether, these data show 
that RIP1  expression induces  caspase-dependent  and -independent  execution in  HaCaT 
cels.  HeLa  cels  undergo  solely  caspase-dependent  death  due to the lack  of  RIP3. 
Moreover,  HeLa  cels  are  more resistant to  RIP1-induced  cel  death,  when  compared to 
HaCaT cels.  
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VII.1.2. Expression of RIP1 leads to kinase-dependent formation of the 
Ripoptosome 
As shown in recent publications95, the observed cel death most likely is induced by the 
formation of a Ripoptosome-like complex, which is able to regulate apoptotic and necroptotic 
cel death responses based on the molecular constitution95,100. To investigate the role of RIP1 
expression and regulation in respect to Ripoptosome formation, immunoprecipitations (IP) of 
caspase-8, a central component of the complex, were performed and analyzed for the co-
precipitation of other Ripoptosome-associated components. Moreover, the impact of caspase 
activation and RIP1 kinase activity in respect to Ripoptosome formation were analyzed by 
the addition of the above-mentioned inhibitors. Therefore, the generated HaCaT and HeLa 
RIP1 WT cels were prestimulated with zVAD-fmk and Nec-1, folowed by the addition of 100 
nM 4-HT. After six hours celular lysates were generated and caspase-8-associated 
complexes were immunoprecipitated as described in the material and methods section.  
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HaCaT and HeLa cels both showed a strong association of caspase-8 with RIP1 and FADD 
(Figure  8A  and  8B).  Additionaly,  cFLIP  was  precipitated together  with  caspase-8 in  HeLa 
cels. Moreover, RIP3 was found to be part of the complex in HaCaT cels (Figure 8A). The 
addition  of the  caspase inhibitor  zVAD-fmk  slightly increased the  co-precipitation  of the 
above-mentioned proteins with caspase-8 (especialy seen in HaCaT cels). This was rather 
expected,  as  caspase inhibition results in the  stabilization  of  caspase-8-containing 
complexes100,144.  The inhibition  of  RIP1  kinase  activity through  Nec-1 largely  suppressed 
Ripoptosome formation as wel as the appearance of higher molecular weight modifications 
on  RIP1 (especialy  seen in  HaCaT  cels).  RIP1 is  post translationaly  modified  via 
phosphorylation and ubiquitination at several sites152. As the inhibition of the kinase activity 
by  Nec-1  suppresses these  modifications, the  seen laddering is  most likely  driven  by 
autophosphorylation  due to  high local  RIP1  concentrations, finaly resulting in the 
phosphorylation-dependent  ubiquitination folowed  by  proteasome-dependent  degradation. 
Summarized, these  data  suggest that the  overexpression  of  RIP1 leads to the formation  of 
the Ripoptosome, containing the proteins caspase-8, RIP1, FADD, cFLIP (in HeLa cels) and 
RIP3 (in HaCaT cels). Moreover, the kinase activity of RIP1 was crucial for the formation of 
this  complex,  as the  addition  of  Nec-1 largely  suppressed the  association  of the  above-
mentioned proteins with caspase-8. 
It is wel known that the RIP1 inhibitor Nec-1 has additional efects apart from inhibiting RIP1 
activity. Several studies showed that the compound for example also suppresses the function 
of the indoleamine-2,3-dioxygenase (IDO)158,159. To  confirm that the  observed  complex 
inhibitory properties of Nec-1 were not simply due to of-target efects, another specific RIP1 
inhibitor (GSK’481)  was tested160.  Moreover, to investigate if  RIP3  kinase  activity is  of 
relevance for  Ripoptosome formation, a  specific  RIP3 inhibitor (GSK’840)  was  used.  This 
second inhibitor  blocks  necroptotic  cel  death  downstream  of  RIP1160.  Therefore, HaCaT 
RIP1 WT cels were prestimulated with GSK’481 and GSK’840 for one hour. RIP1 expression 
was  again induced  by the  addition  of  100  nM  4-HT for  six  hours.  Celular lysates  were 
assessed for  complex formation  by  caspase-8 IP  as  described  above.  Expression  of  RIP1 
again resulted in the  association  of  RIP1,  FADD  and  RIP3  with  caspase-8.  RIP1  kinase 
inhibition through  GSK’481 resulted in  a  dramatic  decrease in  complex formation  and the 
inhibition of higher molecular weight modifications of RIP1. Inhibition of RIP3 downstream of 
RIP1  by  GSK‘840  had  no  efect in terms  of  Ripoptosome formation (Figure  9).  These  data 
confirmed the findings from the last section. Kinase activity of RIP1 is required for substantial 
Ripoptosome formation. Inhibition of downstream necroptotic signaling by the RIP3 inhibitor 
GSK’840 had no efect on the complex formation, indicating that RIP3 kinase activity is not of 
critical relevance for Ripoptosome formation. 
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VII.2. TBK1, IKK-" and TRAF2 are novel components of the Ripoptosome 
 
Thus far, formation and downstream signaling of the Ripoptosome has only been linked to 
cel death induction95,144,161. However, it is very likely that the formation of such an 
intracelular protein complex can also induce non-cel-death signaling cascades, like the 
expression of inflammatory genes through the activation of NF-"B. This is a very common 
concept in intracelular stress signaling, as seen for the TNF complex I, DISC signaling or 
TLR3 stimulation73,107,112. Therefore, further analyses of the Ripoptosome could reveal novel 
components and interacting proteins, which might be responsible for the propagation of such 
signaling pathways. Therefore, highly purified Ripoptosome complexes should be dissected 
by mass spectrometry and analyzed for thus far unknown components. In this respect, the 
above-described necroptotic potent HaCaT system was used, as the expression of RIP1 
induces a strong, kinase-dependent association of the Ripoptosome components RIP1, 
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FADD and RIP3 with caspase-8. Moreover, the expression of the central RIP1 kinase is the 
only trigger for  complex formation  and  downstream  signaling, ruling  out  site  efects from 
diferent stimuli, like death ligands or Smac mimetics. 
 
VII.2.1. Mass spectrometric analysis revealed TBK, IKKε and TRAF2 as integral 
components of the RIP1-induced Ripoptosome 
Novel components of the purified RIP1-induced Ripoptosome should be determined with the 
help of mass spectrometric complex dissection. Therefore, HaCaT RIP1 WT cels were kindly 
analyzed,  by  our  cooperation  partner in  Leicester (Prof.  Marion  MacFarlane from the 
Molecular Mechanisms of Cel Death section, MRC Toxicology Unit) as described before148. 
After the induction  of  RIP1  with  4-HT for six hours, cellular lysates  were  separated  using  a 
Gel-filtration  matrix.  Therefore,  celular lysates  were forced through an agarose  column, 
enabling the  size-dependent  separation  of  unbound  proteins  and  higher  molecular  protein 
complexes (Figure  10A).  When  cels  were  stimulated  with  zVAD-fmk  alone  as  our  control 
condition for  analysis  of  complex formation,  RIP1  and  caspase-8  were  exclusively found in 
lower  molecular  weight fractions (Figure  4A,  botom)  and  no  high  molecular  weight 
complexes were observed. In contrast, when RIP1 expression was induced by 100 nM 4-HT, 
a large portion of both proteins was shifted to the high molecular weight fractions (Figure 4A 
top lane 1-5, marked in red). This indicates the association of RIP1 and caspase-8 in a high 
molecular  weight  complex,  which  we  know is the  Ripoptosome100. In  order to isolate the 
caspase-8-containing  complex from  non-complexed proteins, the  Ripoptosome  containing 
fractions  1-5  were  pooled  and  a  caspase-8 immunoprecipitation  was  performed.  The 
caspase-8-bound  proteins  were  separated  via  SDS-PAGE, folowed  by  coomassie  staining 
(Figure  10B).  Finaly, the protein  bands shown in  Figure  10B, were  analyzed  by  mass 
spectrometry.  The  mass  spectrometric  analysis revealed the  already  known  components 
RIP1, cIAP2 and caspase-8 (Table 1 marked in grey). Surprisingly, it was never possible to 
detect the adapter molecule FADD. However, this could most probably be explained with the 
smal molecular weight of this protein and thereby the detection limit of the technique due to 
the trypsin digestion or via the low required quantities of FADD, as the incorporated amounts 
of  FADD  during Ripoptosome formation  are rather low,  when  compared to  other 
components100,162. Aside from the  already  known  Ripoptosome  components,  some 
contaminating proteins, like the heat shock and stress proteins (HSPA9, HSPA1A, HSPA5 or 
HSPA8),  which  are  often  seen in  mass  spectrometric  analysis,  were found. Interestingly, 
substantial  amounts  of the  non-canonical IKKs,  namely  TBK1  and IKK-ε, together  with the 
E3-ubiquitin ligase TRAF2 were identified (Table 11 marked in red).  
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To confirm the precipitation of TBK1, IKK-! and TRAF2 within the Ripoptosome, these 
proteins were analyzed in RIP1-induced complexes by Western Blot analysis. Moreover, the 
influence of caspase activity as wel as RIP1 kinase activity were analyzed in respect to the 
association of the novel identified components. Therefore, RIP1 WT HaCaT (Figure 11A) and 
HeLa (Figure 11B) cels were stimulated with zVAD-fmk and Nec-1, folowed by RIP1 
expression induced by 100 nM 4-HT for six hours. Caspase-8 was precipitated from celular 
lysates as described above. Furthermore, the coprecipitation of TBK1, IKK-! and TRAF2 with 
caspase-8 was analyzed by Western Bloting (Figure 11). Confirming the mass spectrometric 
results, al three novel components were found associated with caspase-8 in the IP samples. 
The association was, in line with the above-mentioned results, clearly RIP1 expression-
dependent. Moreover, the Western Blot, shown in Figure 11, displays the already seen 
inhibition of complex formation when kinase activity was blocked by Nec-1. The addition of 
zVAD-fmk could, as expected, slightly increase the complex formation. 
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Table	11	Mass	spectrometric	results	of	the	RIP1-induced	purified	Ripoptosome	
Identified	Proteins	 Symbol	 Molecular	Weight	[kDa]	Coverage	
Stress-70protein,	mitochondrial		
OS=homo	sapiens	GN=HSPA9	PE=1	SV=2	
HSPA9	 74	 17	
Caspase-8	
OS=homo	sapiens	GN=CASP8	PE=1	SV=1	
CASP8	 55	 24	
Heat	Shock	70	kDa	protein		
OS=homo	sapiens	GN=HSPA1A	PE=1	SV=5	
HSPA1A	 70	 13	
Receptor	Interacting	Serine/Threonine	Kinase	1	
OS=homo	sapiens	GN=RIPK1	PE=1	SV=3	
RIPK1	 76	 36	
78kDa	glucose	regulated	protein	
OS=homo	sapiens	GN=HSPA5	PE=1	SV=2	
HSPA5	 72	 2	
Serine/Threonine	kinase	TBK1	
OS=homo	sapiens	GN=TBK1	PE=1	SV=1	
TBK1	 84	 11	
Baculoviral	IAP	repeat-containing	protein	2	
OS=homo	sapiens	GN=BIRC2	PE=1	SV=2	
BIRC2	 70	 15	
TNFR-associated	factor	2	
OS=homo	sapiens	GN=TRAF2	PE=1	SV=2	
TRAF2	 56	 19	
Heat	shock	cognate	71	
OS=homo	sapiens	GN=HSPA8	PE=1	SV=1	
HSPA8	 71	 5	
Inhibitor	of	nuclear	factor	kappa-B	kinase	
subunit	epsilon	
OS=homo	sapiens	GN=IKBEK	PE=1	SV=1	
IKKE	 80	 10	
 
Interestingly,  TBK1  and IKK-ε  were  highly  phosphorylated  at  Serine  172  when  RIP1 levels 
were increased. The addition of Nec-1 inhibited the phosphorylation in line with the complex 
formation,  arguing for  a  kinase- or  complex-dependent  activation  of  TBK1  and IKK-ε. 
Additionaly, the phosphorylated state of both proteins was highly enriched in the precipitated 
complex fraction (Figure 11, Caspase-8 IP). Summarized, these findings clearly identified the 
non-canonical IKKs,  TBK1  and IKK-ε,  as  wel  as the  ubiquitin-ligase  TRAF2  as  novel 
components of the RIP1-induced Ripoptosome. Moreover, the kinases TBK1 and IKK-ε were 
substantialy  phosphorylated  at  Serine  172  when  RIP1 level  were increased, indicating the 
activation of both proteins. Furthermore, the activated state of TBK1 and IKK-ε was enriched 
in the caspase-8-bound IP samples. 
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VII.3. The TNF complex I and the TLR3-associated Ripoptosome display 
physiological signaling complexes harboring TBK1, IKK-" and TRAF2 
 
In order to generalize the above-described findings, association of TBK1, IKK-! and TRAF2 
with TNF complex I and the TLR3-induced Ripoptosome-like complex wil be analyzed in the 
folowing section. As shown above, changes in the celular RIP1 level could lead to dramatic 
efects, especialy celular execution. The overexpression of RIP1 represents an extreme and 
quite unphysiological condition. Therefore,the observed interaction between TBK1, IKK-!, 
TRAF2 and caspase-8 could very likely be an artifact of the artificial RIP1 overexpression. In 
contrast, the stimulation of the TLR3 receptor and formation of the TLR3-associated 
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Ripoptosome displays rather physiological processes during pathogen infections. Therefore, 
the TLR3-dependent cel death responses as wel as the formation properties of the TLR3-
associated complex were analyzed and compared to the formation of the TNF complex I.  
 
VII.3.1. Stimulation of the TLR3 receptor with poly (I:C) leads to cel death 
when cIAPs are depleted 
As mentioned above, it was shown that stimulation of the endosomal TLR3 receptor via poly 
(I:C) can also induce cel death and promote the recruitment of the Ripoptosome, when 
cIAPs are depleted100. At first, cel death responses underlying TLR3 stimulation in HaCaT 
and HeLa cels should be analyzed to confirm the published data in the used celular system. 
Moreover, the appropriate concentration of poly (I:C) for the folowing complex analysis 
should be determined.  
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Therefore, parental HaCaT and HeLa cels were stimulated with IAP antagonist (Compound 
A), folowed by the stimulation with diferent concentrations of poly (I:C). HaCaT and HeLa 
cels both showed no cel detachment, meaning no cel death when treated with poly (I:C) 
alone (Figure 12). In the absence of IAP function, poly (I:C)-induced a concentration-
dependent kiling of both cel lines. HeLa cels showed roughly 40% atached cels after 
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treatment with 1 µg/ml poly (I:C). In contrast, HaCaT cels had to be treated with 10 µg/ml in 
order to reach roughly the same amount of atached cels. That means that HeLa cels were 
about ten times  more  sensitive to the treatment than  HaCaT  cels (Figure  12).  Taken 
together, these results confirmed the published data and showed that HaCaT and HeLa cels 
could  be  sensitized to  cel  death  with the  combined treatment  of IAP  antagonist  and  poly 
(I:C).  Moreover,  HaCaT  cel  showed  a roughly ten times  higher resistance to the treatment 
when compared to HeLa cels. For the folowing complex analysis, HaCaT cels were treated 
with  20 µg/ml  and  HeLa  cels  with  2 µg/ml  poly (I:C).  Both  concentrations resulted in 
substantial cel death induction comparable to 10 µg/ml and 1 µg/ml as seen in the functional 
analysis (Figure 12).  
 
VII.3.2. TBK1, IKK-ε and TRAF2 are part of the highly dynamic TLR3-associated 
Ripoptosome 
As  a  next  step, the formation and recruitment of  a  Ripoptosome,  which  could  explain the 
seen  cel  death response  after IAP  antagonist,  should  be  analyzed.  Moreover, the time-
dependent formation of the complex was dissected in order to clarify the optimal stimulation 
time for the  TLR3-associated  Ripoptosome formation.  Hence,  parental  HaCaT  and  HeLa 
cels were prestimulated for one hour with IAP antagonist (Compound A). Additionaly, zVAD-
fmk  was  added,  as this  stabilizes the formation  of  caspase-8  containing  complexes100,144. 
Thereafter,  both  cel lines (HeLa  Figure  13A,  HaCaT  Figure  13B)  were treated  with the 
appropriate  amount  of  poly (I:C).  The  cels  were incubated for  diferent  periods  of time 
folowed by the precipitation of caspase-8 in order to monitor the time-dependent formation of 
the poly (I:C)-induced recruited Ripoptosome (Figure 13). Increased association of RIP1 and 
FADD with caspase-8 was found in a time-dependent manner in both cel lines. Additionaly, 
RIP1 showed increasing phosphorylation at Serine 166 (S166), which is most probably due 
to  clustering  and  autophosphorylation152. Interestingly, the  newly identified  components, 
TBK1, IKK-ε  and  TRAF2  were  also  part  of the  TLR3-associated  Ripoptosome.  Moreover, 
phosphorylated  TBK1  and IKK-ε  as  wel  as  TRAF2 (especialy in  HaCaT)  cels,  seem to 
reach their maximum of association with the complex at an earlier point of time between two 
and four hours (Figure 13A and 13B). These findings indicate that the formation and function 
of the TLR3-associated complex is rather dynamic and is changing over time. Especialy the 
novel identified components; TBK1, IKK-ε  and  TRAF2  are  associated  at  an  earlier  stage in 
complex formation  and  start to  dissociate from the  Ripoptosome four to  six  hours  after the 
beginning  of the  poly (I:C) treatment. Altogether, these findings  validate  TBK1, IKK-ε  and 
TRAF2  as  novel  Ripoptosome  components.  Furthermore, these findings indicate, that the 
above-described  association  of these  proteins  with  caspase-8  complexes is  a related 
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process and not an overexpression artifact of RIP1. Additionaly, the formation of the TLR3-
associated complex is not a linear process as some components reach their maximum of 
association at diferent points of time. 
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In order to further validate the observed association of TBK1, IKK-! and TRAF2 with 
caspase-8, Jurkat cels, representing a suspension T-lymphocyte cel line, were analyzed for 
their ability to form a TLR3 complex in comparison with HeLa cels. Therefore, the Jurkat 
cels were stimulated in line with the control HeLa cels with IAP antagonist (Compound A) 
folowed by incubation with poly (I:C). The formed Ripoptosome was in general weaker than 
the complex detected in HeLa cels. The newly identified components were al precipitated 
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together with caspase-8 (Figure 14). Especialy TBK1 was highly phosphorylated in the 
Jurkat cel line after the poly (I:C) stimulation. Furthermore, RIP3 was found to be part of the 
precipitated complex in Jurkat cels. In summary, HaCaT, HeLa and Jurkat cels, were al 
able to form a TLR3-associated Ripoptosome upon the combined treatment with poly (I:C) 
and IAP antagonist. In line with the RIP1-induced Ripoptosome, the TLR3-associated 
complex revealed TBK1, IKK-! and TRAF2 as novel components of the Ripoptosome. 
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VII.3.3. TLR3-associated Ripoptosome formation is RIP1-dependent 
As  previously  described,  RIP1 is the  central  component  of the  Ripoptosome  and  RIP1-
induced  complex formation  was  highly  dependent  on the  kinase  activity.  For the  TLR3-
associated  complex,  RIP1  was  shown to  act  upstream  of  FADD163.  After  TLR3  stimulation, 
the adaptor molecule TRIF is recruited to the receptor. Thereafter, RIP1 can bind to TRIF via 
its RHIM domain. RIP1 can now act as an adaptor for the recruitment of FADD and caspase-
8, thereby enabling Ripoptosome formation and linking this complex to the TLR3 receptor164. 
In order to clarify whether RIP1 is crucial for TLR3-related cel death, Ripoptosome formation 
as wel as activation of TBK1 and IKK-ε, HeLa knockout cel lines were generated. Therefore, 
parental  HeLa  cells  were transfected  with the  CRISPR/Cas9  system  containing  a  gRNA 
targeting  RIP1  as  described in the  material  and  method  section.  After  single  cel  selection, 
two clones were identified and used for further experiments. 
 
 
Figure	15	Loss	of	RIP1	blocks	poly	(I:C)-induced	cel	death	in	the	absence	of	cIAPs.	
RIP1	deficient	and	control	HeLa	cels	were	incubated	with	100	nM	IAP	antagonist	(Compound	A)	folowed	by	
incubation	with	diferent	concentrations	of	poly	(I:C)	for	20	h.	Cel	attachment	was	analyzed	by	crystal	violet	
staining.	The	shown	data	display	the	mean	values	±	SEM	of	three	independent	experiments.	
 
When treated with IAP antagonist and poly (I:C), both cel lines showed a complete inhibition 
of  cel  death,  whereas the  control  cels  died  with increasing  concentrations  of  poly (I:C) 
(Figure 15). When the association of complex components with caspase-8 was analyzed, the 
RIP1  deficient  cels  showed  a total inhibition  of  complex formation (Figure  16).  Moreover, 
caspase-8  and  cFLIP  cleavage  was  only  observed  when  RIP1  was  present.  Surprisingly, 
phosphorylation  of IKK-ε  was  massively  decreased  when  RIP1  was  absent,  whereas the 
phosphorylation of TBK1 seemed to be unafected.  
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That was rather unexpected, as TBK1 and IKK-ε were reported to be activated by the direct 
binding to  TRIF  upon TLR3  stimulation,  meaning that  RIP1 is  not  necessary for the 
phosphorylation of the non-canonical IKKs105. However, in the shown HeLa knockout system 
this  was  only  observed for  TBK1.  The  phosphorylation  of IKK-ε is  massively  dependent  on 
RIP1.  Altogether, these  data  confirmed that  RIP1 is indispensable for IAP  antagonist  and 
poly (I:C)-induced Ripoptosome formation and cel death induction. Surprisingly, loss of RIP1 
showed  a  severe  efect  on the  activation  of IKK-ε,  whereas  TBK1  phosphorylation  was  not 
altered.  
 
VII.3.4. TBK1, IKK-ε and TRAF2 are components of the TNF complex I 
As  mentioned in the introduction,  binding  of  TNF to the  TNFR1 induces the intracelular 
formation  of the  TNF  complex I,  whose  main function is the induction  of inflammatory  and 
pro-survival genes via NF-κB54. However, under certain celular conditions, e.g. the depletion 
of  cIAPs, this receptor  bound  complex  can  dissociate into the  cytosol to form the  TNF 
complex I. This complex possesses the ability to induce cel death via caspase activation or 
Necrosome formation80. Remarkably, there is stil an ongoing debate whether TNF complex 
I, which is only observed under depleted cIAP level, is a Ripoptosome-like complex that is 
stabilized  and increased through the  additional  TNF  stimulation.  However, in the folowing 
section the  association  of the  newly identified  proteins  TBK1, IKK-ε  and  TRAF2  with  TNF 
signaling complex I should be analyzed, in line with the RIP1-induced Ripoptosome and the 
TLR3-associated  complex.  Thereby the  combined treatment  of the  poly (I:C)  and IAP 
antagonist was used as a control for complex formation. Additionaly, the impact of Etoposide 
treatment in respect to  complex formation  should  be  analyzed.  The  group  of  Pascal  Meier 
showed that genotoxic stress, simulated by Etoposides, could also induce the association of 
caspase-8  with  Ripoptosome  components  due to  depletion  of  celular  cIAP level144. 
Therefore,  HaCaT  cels  were  prestimulated  with IAP  antagonist (Compound  A) in 
combination  with  zVAD-fmk  or  with  zVAD-fmk  alone for  one  hour.  Thereafter,  cels  were 
stimulation with TNF, poly (I:C) or Etoposides for six hours. Cels stimulated with Etoposides 
showed  no formation  of  a  caspase-8  associated  complex (Figure  17).  The  group  of  Pascal 
Meier showed that substantial complex formation in line with cIAP depletion is reached after 
a twenty-four hour Etoposide treatment144. Therefore, the six-hour incubation time was most 
probably too  short for the  depletion  of the  celular IAP levels.  Cels treated  with IAP 
antagonist in  combination  with  TNF  showed, in line  with the  data  of the  RIP1-induced 
Ripoptosome, that TBK1, IKK-ε and TRAF2 were associated with caspase-8 (Figure 17). The 
non-canonical IKKs again were phosphorylated and the activated state was enriched in the 
precipitated fractions (IP).  Moreover, the  precipitated  proteins  were  analyzed for  TRADD, 
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which is the classical adaptor for TNF complex I and is also associated with the cytosolic 
TNF complex I. However, some reports also highlighted a role for TRADD in TLR3 signaling, 
as knockout cels were resistant to TLR3-induced toxicity165,166. The now precipitated 
complexes, clearly show that TRADD is associated with the poly (I:C)-induced, TLR3 bound 
Ripoptosome (Figure 17, IP) and TNF complex I. Taken together, these data highlight the 
association of TBK1, IKK-! and TRAF2 with TNF complex I. Moreover, TRADD is part of the 
TLR3-bound Ripoptosome. Based on these results, there were no observed diferences in 
TNF complex I and the TLR3-associated Ripoptosome. 
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VII.4. TBK1  and IKK-ε  do  not influence  cel  death  but loss  of  TRAF2 
sensitizes to PCD 
 
The  above-shown  experiments  clearly identified  TBK, IKK-ε and  TRAF2  as  novel 
components  of the  Ripoptosome  as  wel  as  TNF  complex I.  However, the tasks  of these 
proteins in this  signaling  complex remained to  be  elusive.  As the  Ripoptosome is  able to 
induce  apoptosis  as  wel  as  necroptosis, the impact  of the  novel  components in respect to 
cel death responses were analyzed. 
 
VII.4.1. TRAF2 inhibits cel death upon RIP1 expression 
The E3-ubiquitin ligase TRAF2 is long time known for its essential function in TNF complex I 
mediated  NF-κB  activation77,167,168.  However, recent  studies  also  highlighted that  TRAF2 
inhibits  CD95L- and  TNF-induced  cel  death169,170.  As  TRAF2 is  clearly associated  with the 
Ripoptosome, the impact  of  cel  death  was  analyzed,  using the  RIP1  expressing  HaCaT 
cels. In line with the above mentioned experiments, HaCaT RIP1 WT cels were transfected 
with  diferent  siRNAs targeting  TRAF2 (Figure  18A).  The  siRNAs  4,  6  and  7  showed  a 
substantial reduction in the  TRAF2  protein level (Figure  18A)  when  compared to the 
scrambled control siRNA (Ctrl siRNA). The best working siRNAs (TRAF2 siRNA 4, 6, 7) were 
pooled for further  experiments in  order to reduce the of-target  efect  of  single  siRNAs. 
HaCaT cels transfected with the TRAF2 siRNA pool showed substantial knockdown of the 
target  protein,  comparable to the  TBK1  and IKK-ε  siRNAs  described in the  next  section 
(Figure 18B). Next, the influence of reduced TRAF2 expression on cel death responses was 
analyzed  by  crystal  violet  assays.  Therefore, HaCaT  RIP1  WT  cels  were transfected  with 
control siRNA (Ctrl siRNA) and the TRAF2 siRNA pool. Three days after transfection, cels 
were  stimulated  with  zVAD-fmk  and  Nec-1, in  order to  clarify  whether  an  efect  of  TRAF2 
reduction  can  be  unmasked  by  caspase inhibition  or  block  of  RIP1  kinase function. 
Thereafter,  cels  were incubated  with  diferent  concentrations  of  4-HT for twenty  hours. 
Interestingly, the TRAF2 knockdown sensitized the HaCaT RIP1 WT cels against cel death 
induced  by low  amounts (1nM)  of  4-HT (Figure  18C).  Surprisingly,  under  conditions  where 
caspase  activity  was  blocked  by  zVAD-fmk, the  knockdown  showed  no  diference in  cel 
atachment  compared to the  Ctrl  siRNA treated  cels.  These findings implicated that the 
observed phenotype was rather due to changes in the apoptotic signaling pathway. This was 
further confirmed by the fact, that the addition of Nec-1 showed again a sensitization against 
RIP1-induced  cel death in the  cels treated  with  TRAF2  siRNA (Figure  18C, red  bars).  As 
expected, when apoptotic and necroptotic cel death was blocked by the combination of the 
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caspase inhibitor zVAD-fmk and the RIP1 inhibitor Nec-1, no diference between the Ctrl 
sample and the TRAF2 knockdown was observed for cel death induction. Altogether, these 
data indicate that TRAF2 inhibits RIP1-induced apoptotic cel death. In contrast, the caspase-
independent necroptotic cel death response is not influenced by the reduction of TRAF2 
protein level. 
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VII.4.2. TBK1 and IKK-" do not influence cel death signaling in RIP1 
overexpressing cels 
After the encouraging finding that TRAF2 knockdown sensitized against RIP1-induced 
apoptosis, the influence of TBK1 and IKK-! on PCD was assessed. Therefore, diferent 
siRNAs were tested for the ability to deplete TBK1 and IKK-! protein levels in HaCaT RIP1 
WT cels. Three days after the transfection, knockdown eficiency was monitored by Western 
Blot analysis. Cels treated with the TBK1 siRNAs A, B, D and the IKK-! siRNAs B, C, D 
showed a substantial decrease of the target protein level (Figure 19A and 19B). In line with 
the TRAF2 siRNAs, a pool of the best working siRNAs (namely TBK1 A, B, D and IKK-! B, C, 
D) was generated to reduce of-target efects of single siRNAs. 
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Cels treated with TBK1 and IKK-ε or the combined siRNAs, showed significant reduction in 
the TBK1 and IKK-ε protein level (Figure 19B). In order to analyze the cel death dependency 
of TBK1 and IKK-ε, HaCaT RIP1 WT cels were transfected with the above mentioned siRNA 
pools.  As  previously  described, the  non-canonical IKKs  can  substitute for  each  other in 
respect  of IRF3  phosphorylation.  Hence,  an  additional,  simultaneous  knockdown  of  both 
kinases was performed. Therefore, siRNAs for TBK1 were also pooled with IKK-ε siRNAs in 
order to generate a double knockdown (Figure 19B). Finaly, celular execution was induced 
with the  expression  of  RIP1,  by the  addition  of  diferent  concentrations  of  4-HT for twenty 
hours. Cel viability was visualized by crystal violet assay. 
The Ctrl siRNA treated cels showed substantial cel death with increasing concentrations of 
4-HT, equaling increasing RIP1 expression. The addition of the caspase inhibitor zVAD-fmk 
could rescue  up to  50%  of the  cels.  The remaining  cel  death  was  observed,  because 
HaCaT cels are able to undergo necroptosis. In contrast, the RIP1 inhibitor Nec-1 had only a 
minor  efect,  especialy  on  high  concentrations  of  4-HT (100  nM).  As  expected, the 
combination  of  both inhibitors  blocked  cel  death  completely.  However,  when  compared to 
the  control  siRNA treated  cels,  TBK1, IKK-ε  or the  combined  knockdown  had  no  efect  on 
the cel death response due to the expression of RIP1 (Figure 19C). 
In  summary,  substantial reduction in  TBK1  and IKK-ε  protein level  had  no influence  on the 
cel death responses carried out by the overexpression of RIP1. 
 
VII.5. The loss of TBK1, IKK-ε or TRAF2 does not influence Ripoptosome 
formation 
 
As  shown for  RIP1 in  TLR3  signaling, the loss  of single  components  can  suppress the 
formation  of the  Ripoptosome  and, therefore, RIP1-dependent  cel  death responses.  To 
analyze the impact of the newly identified components on complex formation, HeLa cel lines 
deficient for TRAF2, TBK1, IKK-ε and the combination of both IKKs were generated using the 
CRISPR/Cas9 technology  as  described in the  material  and  methods  section.  Two  clones, 
positive for the knockout of the target gene were analyzed in the folowing experiments. The 
protein level  of the integral  Ripoptosome  components;  caspase-8,  FADD,  RIP1,  cFLIP, 
TBK1, IKK-ε  and  TRAF2,  as  wel  as the  necroptotic relevant  pseudokinase  MLKL  were  not 
altered by the knockout of TBK1, IKK-ε or TRAF2 (Figure 20). 
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When the cels were treated with IAP antagonist plus TNF or poly (I:C), the TBK1/IKK-! 
double knockout cel line showed no significant alteration in their cel death response when 
compared to the control cel line (Figure 21). The TRAF2 knockout clones, showed a clear 
sensitization against the combined treatment of IAP antagonist plus TNF or poly (I:C). This 
again showsthat TRAF2 inhibits cel death induction (Figure 21). 
Ripoptosome formation in these cel lines was induced with the combined treatment of IAP 
antagonist and poly (I:C). For the TBK1/IKK-! double knockout, two additional clones were 
analyzed. These additional clones (IKK-!/TBK KO) were generated vice versa, meaning that 
IKK-! knockout cels were transfected with a TBK1 CRISPR construct, in order to rule out 
clonal selection efects. Al knockout cel lines showed substantial formation of the 
Ripoptosome (Figure 22A).  
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The adaptor molecule TRADD was precipitated in al knockout cels together with caspase-8 
upon IAP antagonist and poly (I:C) treatment. Surprisingly, loss of TBK1, seemed to result in 
a lesser recruitment of components like cFLIP or RIP1 to the complex, when compared to the 
control or other knockout cels (Figure 22A). Interestingly, TRAF2 seems to behave the other 
way  around.  When TBK1 is lacking,  TRAF2 is  enriched in the  precipitated  complex. 
However, in the  second  set  of  clones, this  was  not true for the IKK-ε/TBK1  KO  cel line 
(Figure  22B),  which might  be explained  by clonal  selection  processes. Summarized, these 
data again highlight that TRADD is also part of the TLR3-associated Ripoptosome. Although, 
loss of the newly identified components TBK1, IKK-ε or TRAF2 did not inhibit Ripoptosome 
formation, lack  of  TBK1  seemed to  change the  stoichiometric  composition  of the  complex. 
Both,  cFLIP  and  RIP1  are recruited to  a lesser  extent,  whereas  TRAF2 is  enriched in the 
caspase-8  precipitated fractions.  These findings indicate that  TBK1  might  stabilize the 
binding of cFLIP and RIP1 with caspase-8, thereby competing with TRAF2 association. 
 
VII.6. Ripoptosome formation induces expression of NF-κB target genes 
 
TRAF2 was already known to be involved in the cel death execution induced by CD95L or 
TNF169,170. Additionaly, the above shown results highlight the role of TRAF2 in inhibiting poly 
(I:C)- and RIP1-induced apoptotic cel death responses. However, the role of TBK1 and IKK-
ε in Ripoptosome-mediated signaling stil remained to be elusive. As both proteins are known 
to interact and activate proteins of the NF-κB pathway, the gene inductive properties of the 
Ripoptosome were analyzed. Hence, RIP1 expressing HaCaT cels were stimulated with 4-
HT and poly (I:C) in combination with IAP antagonist for several points of time (Figure 23).  
When Ripoptosome formation was induced with 4-HT-mediated RIP1 expression, TBK1 and 
IKK-ε became phosphorylated five hours after stimulation, in line with the expression of the 
kinase  RIP1 (Figure  23A).  Moreover,  a phosphorylation  of  MLKL  was  observed, indicating 
the induction  of  necroptosis. Interestingly, the  phosphorylation  of IκB-α  as  wel  as  p65 
became  visible  at the  same  points of time (Figure  23A).  The  protein levels  of the  non-
canonical  p100/p52  NF-κB  proteins  were  not  altered.  Additionaly, the transcription factor 
IRF3 was not activated after RIP1 expression (Figure 23A). In total, these data show that the 
expression  of  RIP1 induces the  activation  of the  canonical  NF-κB  pathway,  but interferon 
responses carried out by the transcription factor IRF3 are not observed upon RIP1-induced 
Ripoptosome formation. 
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When stimulated with the TLR3 antagonist poly (I:C), TBK1 and IKK-! were subsequently 
activated after one hour and remained their phosphorylation status over time (Figure 23B). 
The phosphorylation of I"B-$ started also one hour after stimulation and increased with the 
time of poly (I:C) treatment. In contrast, the activation of p65 reached a maximum between 
one and three hours after the start of the stimulation (Figure 23A). Furthermore, the non-
canonical NF-"B p100 was cleaved into its functional p52 fragment. This efect was 
expected, as the depletion of cIAP level by IAP antagonists is known to stabilize NIK and 
thereby activates the non-canonical NF-"B pathway171. 
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Additionaly, the IRF3 transcription factor became highly phosphorylated two to three hours 
after the start of the treatment, showing the TLR3-dependent production of Type I 
interferons106,172 (Figure 23B). In summary, the poly (I:C) data showed, that there is an early, 
Ripoptosome-independent NF-"B response between one and three hours, in line with the 
activation of IRF3. However, a  secondary, canonical NF-"B response is shown by the 
increasing phosphorylation of I"B-$. 
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To clarify whether the observed NF-"B induction results in the upregulation of specific target 
genes, mRNA level were analyzed over time via qPCR. Therefore, HaCaT RIP1 WT cels 
were stimulated with Nec-1 and zVAD-fmk, as the impact of RIP1 kinase activity on mRNA 
regulation should be analyzed and the caspase inhibitor is known to further increase 
complex-mediated gene induction117. After an one hour incubation with the respective 
inhibitor, RIP1 expression was induced by the addition of 4-HT for the indicated points of 
time. After the incubation, celular RNA was isolated and probed for the NF-"B target genes 
IL-8 (Interleukin-8, also CXCL8) and PAI-2 (the plasminogen activator inhibitor-2, also 
SERPINB2) (Figure 24). IL-8 is one of the classical NF-"B targets138,173,174. The upregulation 
and secretion of the IL-8 protein is often seen  during stress responses, leading to the 
induction of inflammatory processes173. Additionaly, the regulation of PAI-2 was analyzed, as 
the upregulation of this protein was shown to play a major role in inhibiting TNF-induced 
apoptosis. This is carried out by the stabilization of transglutaminase 2 (TG2), which limits 
procaspase-3 activation175. Moreover, the induction of PAI-2 was shown to be dependent on 
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TBK1 when stimulated with TNF175. Interestingly, both mRNA level were upregulated over 
time in line with the expression of RIP1. As expected, the addition of zVAD-fmk, further 
increased the upregulation of the target genes. In contrast, the stimulation with Nec-1 
reduced NF-"B-dependent gene induction (Figure 24). This shows, in line with the 
biochemical complex analysis, that RIP1 kinase activity is necessary for RIP1-induced 
Ripoptosome formation and thereby NF-"B activation.  
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To analyze a broader subset of genes as wel as to elucidate the impact of TBK1 and IKK-! 
on the gene inductive properties of the Ripoptosome, micro array analyses of HaCaT RIP1 
WT cels were performed. Therefore, cels were transfected with control siRNA or the 
combination of TBK1 and IKK-! siRNAs in three independent experiments. Additionaly, 
control siRNA treated cels were stimulated with the RIP1 inhibitor Nec-1, as kinase inhibition 
should result in a decrease of Ripoptosome-mediated gene expression as shown in Figure 
24. Three days after transfection, cels were stimulated with 4-HT for eight hours to induce 
complex formation. Successful knockdown of the target proteins was monitored by Western 
Blot analysis and showed a substantial reduction of the target protein level (Figure 25B). 
Additionaly, RNA was isolated and probed for IL-8 induction by qPCR as a control. After 
RIP1 induction, IL-8 was massively upregulated. The addition of Nec-1 could again reduce 
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the gene induction. The combined knockdown of TBK1 and IKK-ε was also able to decrease 
the IL-8 induction about 25% (Figure 25A). In order to further evaluate these findings, mRNA 
expression of the three independent experiments was compared by micro array analysis for 
the whole genome RNA. Therefore, RNA expression was compared between the respective 
unstimulated control and 4-HT stimulated samples. The array analysis was kindly performed 
by the lab of Dr. Martin Sprick from Hi-STEM at the DKFZ and by the DKFZ genomics and 
proteomics core facility.  
 
Table	12	Micro	Array	analysis	of	RIP1	expression-dependent	gene	induction	
Ctrl vs. Ctrl + 4-HT  Nec-1 vs. Nec-1 + 4-HT  TBK1/IKK-ε KD vs. TBK/IKK-ε + 4-HT 
Gene	 Fold	
change	
P	value	 	 Gene	 Fold	
change	
P	value	 	 Gene	 Fold	
change	
P	value	
IL8	 25.35	 3.02E-29	 	 IL8	 17,43	 4,07E-19	 	 IL8	 21,50	 7,11E-13	
IL8	 17.28	 5.38E-18	 	 HES5	 8,97	 3,79E-38	 	 IL8	 12,87	 5,57E-14	
HES5	 8.76	 1.77E-52	 	 IL8	 8,54	 2,96E-14	 	 HES5	 8,95	 2,20E-39	
CXCL1	 7.25	 5.94E-14	 	 SIAH2	 8,53	 6,64E-51	 	 TMEM2	 6,84	 1,12E-44	
TMEM2	 6.51	 4.38E-59	 	 TMEM2	 7,21	 1,53E-36	 	 JUN	 6,40	 1,10E-37	
SIAH2	 6.44	 4.41E-47	 	 SLC16A3	 5,07	 1,69E-62	 	 SIAH2	 5,84	 2,64E-37	
TNFAIP3	 5.91	 1.40E-25	 	 JUN	 4,65	 1,32E-53	 	 CXCL1	 5,61	 1,00E-13	
BMP2	 5.85	 1.58E-40	 	 BMP2	 4,60	 6,43E-40	 	 TNFAIP3	 5,40	 2,44E-23	
JUN	 5.23	 1.83E-43	 	 TP53INP1	 4,15	 3,51E-43	 	 SLC16A3	 5,27	 5,29E-43	
SLC16A3	 4.83	 2.73E-48	 	 CXCL1	 4,06	 1,06E-12	 	 SERPINB2	 4,43	 5,13E-15	
CCL20	 4.47	 6.64E-19	 	 IRF1	 3,66	 1,90E-41	 	 BMP2	 4,34	 8,40E-35	
NFKBIZ	 4.33	 1.24E-40	 	 TP53INP1	 3,594	 4,94E-35	 	 LOC650757	 4,04	 1,66E-45	
ATF3	 4.24	 5.04E-29	 	 BCOR	 3,55	 4,53E-44	 	 IRF1	 3,97	 3,01E-42	
IRF1	 4.06	 4.70E-44	 	 CCL20	 3,50	 9,70E-23	 	 HBEGF	 3,91	 5,43E-19	
DUSP1	 3.81	 2.65E-41	 	 RTN4R	 3,47	 3,16E-32	 	 DUSP1	 3,87	 6,60E-27	
BCOR	 3.67	 1.33E-35	 	 ODC1	 3,47	 2,68E-38	 	 NFKBIZ	 3,84	 6,41E-27	
NFKBIA	 3.58	 2.23E-29	 	 CASP7	 3,41	 2,39E-34	 	 SERPINB2	 3,82	 6,04E-22	
TP53INP1	 3.53	 1.93E-42	 	 CBX4	 3,28	 2,49E-25	 	 BCOR	 3,81	 2,24E-38	
SERPINB2	 3.51	 6.39E-33	 	 FAM46C	 3,18	 1,09E-21	 	 CCL20	 3,78	 2,12E-16	
RTN4R	 3.47	 4.73E-37	 	 CAT	 3,02	 1,16E-23	 	 C17ORF96	 3,63	 2,62E-24	
C17ORF96	 3.43	 3.01E-35	 	 LOC65075	 2,96	 4,05E-38	 	 FOSL1	 3,61	 1,59E-47	
EGR1	 3.33	 1.12E-26	 	 FAM117B	 2,93	 5,83E-35	 	 NFKBIA	 3,51	 2,68E-24	
SERPINB2	 3.30	 1.19E-29	 	 TNFAIP3	 2,84	 2,27E-22	 	 ATF3	 3,16	 4,47E-44	
SLC25A24	 3.28	 1.19E-15	 	 C17ORF96	 2,83	 6,29E-45	 	 CLCF1	 3,15	 1,20E-19	
CBX4	 3.27	 1.86E-20	 	 NFKBIZ	 2,83	 3,32E-47	 	 IL1A	 3,09	 8,12E-20	
TP53INP1	 3.25	 7.88E-39	 	 FOXC1	 2,81	 1,74E-27	 	 CASP7	 2,99	 9,96E-32	
TNF	 3.20	 2.82E-28	 	 FOSL1	 2,77	 1,11E-44	 	 KLF6	 2,90	 4,43E-25	
FAM46C	 3,18	 8,28E-33	 	 ATF3	 2,73	 2,56E-20	 	 EGR1	 2,86	 3,53E-30	
LOC65075	 3,11	 1,05E-37	 	 CAT	 2,63	 2,64E-36	 	 ZFP36	 2,84	 1,08E-23	
FOSL1	 3,09	 2,58E-46	 	 SERPINB2	 2,57	 3,21E-39	 	 FAM46C	 2,77	 1,17E-26	
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The  30  most regulated  genes  of the  comparison  are  shown in  Table 12.  The  upregulated 
genes represent typical NF-κB-related targets and genes involved in activation of cytokines 
like TNF and chemokines like CXCL1 or CCL20. The top regulated gene is IL-8, which was 
also  observed by the qPCR  experiments. In line  with the  biochemical  and  qPCR  data, the 
gene induction could be reduced by the addition of Nec-1. The absolute fold change of the 
IL-8 mRNA was decreased from roughly 25 to 17, which displays a reduction of ~30%. The 
combined  knockdown  of  TBK1  and IKK-ε  decreased the IL-8 induction from  25 to  21 (~ 
15%). This was also true for other inflammatory genes like CXCL1 (roughly 7 to 5; ~ 25%) or 
CCL20 (roughly 4.5 to 3.8; ~ 20%). Interestingly, the SERPINB2 gene was also upregulated 
after  RIP1 induction. In line  with the IL-8 results,  Nec-1 reduced the induction  substantialy 
from 3.5 to 2.5, meaning again a reduction of ~ 30%. However, the induction of SERPINB2 
was not reduced when TBK1 and IKK-ε were knocked down by siRNA. 
Summarized, these  data  clearly  show the  gene inductive  properties  of the  Ripoptosome, 
which are highly dependent on the kinase activity of RIP1. Moreover, the upregulation of the 
shown mRNAs displays the induction of an inflammatory response carried out by NF-κB with 
IL-8 as the  most  dominant regulated  gene.  The reduction  of  TBK1  and IKK-ε  protein level 
could reduce the RIP1-induced proinflammatory gene expression, shown by IL-8, CXCL1 or 
CCL20.  These results indicate that  TBK1  and IKK-ε  support  Ripoptosome-mediated 
proinflammatory responses. However, the influence of TBK1 and IKK-ε in respect to PAI-2175 
induction, could not be verified in terms of the RIP1-induced Ripoptosome, indicating that a 
subset of upregulated genes is not regulated by TBK1 or IKK-ε. 
 
VII.7.TBK1  and IKK-ε induce  phosphorylation  of  autophagy receptors 
after Ripoptosome formation 
 
As  mentioned in the introduction, the  non-canonical IKKs  are involved in  many  diferent 
celular  signaling pathways.  Some recent  studies  also  connected  TBK1 to the 
phosphorylation  of  autophagic receptors like  optineurin (OPTN)  and  sequestosome-1 
(SQSTM1  or  p62),  which  are  sensing  damaged mitochondria  or  microbial infections, finaly 
inducing autophagic removal141–143. To assess whether Ripoptosome formation results also in 
the  TBK1- and IKK-ε-mediated  activation  of  autophagic receptors,  SILAC (stable isotope 
labeling  with  amino  acids in  cel  culture) labeling  and  mass  spectrometric  analysis  of the 
phosphosites were analyzed in HeLa RIP1 WT TBK1/IKK-ε deficient cels. Therefore, HeLa 
Ctrl and TBK1/IKK-ε knockout cels with inducible RIP1 expression were established. 
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In order to rule out functional changes due to clonal selection, RIP1 expression as wel as 
cel death responses were analyzed in the newly established cel lines. Therefore, expression 
of RIP1 was induced by 4-HT for six hours and RIP1 expression was monitored by Western 
Blot analysis (Figure 26A). Al cel lines showed comparable expression of RIP1 after the 4-
HT treatment. Cel death induction was visualized by crystal violet staining after stimulation 
with diferent concentrations of 4-HT in combination with zVAD-fmk and Nec-1 for twenty 
hours, as described above. The control cel line as wel as the double knockout showed 
significant reduction in cel atachment with increasing concentrations of 4-HT. As seen 
before, the addition of the caspase inhibitor zVAD-fmk could completely block cel death, 
whereas treatment with the RIP1 kinase inhibitor Nec-1 could only partialy block celular 
execution (Figure 26B). These results rule out possible changes in the expected functionality 
in terms of RIP1 expressing, due to clonal selection. Hence, the generated cels could then 
be used in the mentioned phosphosite analysis.  
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The SILAC labeling and mass spectrometric analyses described in the folowing section were 
kindly  done  by the lab  of Ivan  Dikic from the Institute  of  Biochemistry I,  Goethe  University 
Medical School in Frankfurt. In brief, HeLa RIP1 WT and TBK/IKK-ε KO RIP1 WT cels were 
grown in medium containing heavy (HeLa WT) or light (TBK/IKK-ε KO) isotope labeled amino 
acids.  When the labeled  cels reached  a  certain  confluence,  RIP1  expression  was induced 
with 4-HT and Ripoptosome formation was assayed by caspase-8 IP as seen in Figure 27. 
Caspase-8  was  completely  depleted from the  protein lysates  after the IP (Figure  27  Sup. 
after IP). As the only purpose of this experiment was to verify the ability of the generated cel 
lines to form a Ripoptosome, bound proteins of the WT and TBK/IKK-ε knockout cels were 
pooled  after the  caspase-8  precipitation.  The  combined  samples  of the  Ctrl  and  knockout 
cels  showed  a  substantial  co-precipitation  of  RIP1,  FADD  and  phospho-TBK together  with 
caspase-8.  Additionaly  TBK1  was  phosphorylated in the  WT  cels  upon  RIP1  expression. 
For  phosphosite  analysis, both  cel lines  were  again  grown in  medium  containing labeled 
amino  acids.  Total  celular lysates  were  generated  after  RIP1 induction  and  mixed in  a  1:1 
ratio.  The  combined  samples  were finaly analyzed for  diferences in the  phosphorylation 
status by mass spectrometry. 
 
Table	13	Selected	phosphoproteome	analysis	in	HeLa	TBK1/IKK-ε	knockout	cels	
Name	 Gene	 Position	 H/L	Ratio	
Sequestosome-1	 SQSTM1	 277;361	 13,186	
Receptor-interacting	
serine/threonine-protein	kinase	1	
RIPK1	 25;25	 11,664	
Sequestosome-1	 SQSTM1	 282;366	 9,617	
TNF	receptor-associated	factor	2	 TRAF2	 7;7;7;7;7;7;7;7	 5,5734	
E3	ubiquitin-protein	ligase	XIAP	 XIAP	 5;5;5	 5,5438	
TNF	receptor-associated	factor	2	 TRAF2	 11;11;11;11	 4,5564	
Transcription	factor	AP-1	 JUN	 243	 3,6255	
Optineurin	 OPTN	 120;177;177;120	 3,3097	
TGF-beta-activated		
kinase	1	and	MAP3K7-binding	protein	2	
TAB2	 582	 2,704	
Receptor-interacting	
serine/threonine-protein	kinase	1	
RIPK1	 320;274	 2,1382	
 
Shown in Table 13 are selected results from the phosphosite analysis. The autophagy cargo 
adaptor  sequestosome-1 is roughly thirteen times  more  phosphorylated  at  Serine  277  and 
Serine 361 and roughly ten times more phosphorylated at Serine 282 and Serine 366 when 
TBK1 and IKK-ε were present (Table 13 marked in red). Additionaly, the mitophagy adaptor 
optineurin is  phosphorylated  at  Serine  120  and  Serine  177 in  a  TBK1/IKK-ε-dependent 
manner. Interestingly,  RIP1  was  also  eleven times  more  phosphorylated  at  S25  and two 
times more phosphorylated at Serine 320 and Serine 274 when the non-canonical IKKs were 
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present. Additionaly, the phosphorylation status of TRAF2 was changed at two sites (Serine 
7 and Serine 11) in the knockout cel line. The NF-κB linker TAB2 was also influenced by the 
loss  of  TBK1 and IKK-ε,  supporting the  above-shown involvement  of  TBK1  and IKK-ε in 
Ripoptosome  mediated  NF-κB induction.  Moreover, the  anti-apoptotic  XIAP  protein is 
phosphorylated in a TBK1-dependent manner. In line with this, the transcription factor AP-1 
(JUN) is phosphorylated, indicating the induction of anti-apoptotic pro-survival responses.  
In  summary, these  data  show that  autophagy  adaptors like  sequestosome-1  or  optineurin 
were phosphorylated after RIP1 expression in a TBK1- and IKK-ε-dependent manner. These 
findings might implicate that TBK1 and IKK-ε are responsible for the activation of autophagy 
during  RIP1-induced  Ripoptosome formation.  However, this  has to  be  validated through 
further  experiments.  The  NF-κB  activator  TAB2  was  also phosphorylated in  a  TBK1/IKK-ε-
dependent manner. This might explain the above described decrease in NF-κB target gene 
expression  after  TBK1/IKK-ε  knockdown.  Furthermore, the  phosphorylation  state  of 
Ripoptosome  components (RIP1,  TRAF2)  as  wel  as  anti-apoptotic  proteins (XIAP,  TRAF2, 
JUN)  were influenced  by  TBK1  and IKK-ε.  Altogether  both  kinases influence the 
phosphorylation  of  diferent  proteins,  which  are  known to  be involved in  Ripoptosome,  cel 
death  and  NF-κB  signaling as  wel  as the  autophagic  pathway.  However, for  a final 
clarification of the role of TBK1 and IKK-ε function within the Ripoptosome for the regulation 
of autophagic and non-cel death signaling pathways further experiments are needed.  
 
Altogether, the results in this thesis  clearly identified  TBK1, IKK-ε  and  TRAF2  as  novel 
Ripoptosome  components.  Moreover,  TRAF2  could  be  verified  as  a  potent  apoptosis 
inhibitor,  whereas  TBK1  and IKK-ε  had  no influence  on  Ripoptosome-mediated  cel  death 
signaling. Interestingly, it could be also shown that complex formation was not only inducing 
cel  death  but  also  holds the  possibility  of  gene induction  via  NF-κB.  These  gene inductive 
properties were dependent on the kinases TBK1 and IKK-ε. Last, but not least, Ripoptosome 
induction  was inducing the  phosphorylation  of  autophagy receptors in  a  TBK1- and IKK-ε-
dependent  manner.  Hence, it  can  be  speculated that  complex formation  possibly  activated 
the  autophagic  machinery.  Altogether, the  generated results  shed  new light into 
Ripoptosome  composition  and  signaling  and  are, therefore, of  great interest for the 
understanding of this celular stress sensor. 
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IX. Discussion 
 
The decision between celular execution and cel survival is a tightly regulated mechanism in 
the life  cycle  of  multicelular  organisms. Deregulations in these processes can have severe 
consequences176 including the appearance of several diseases like multiple sclerosis 177,178 or 
lupus  erythematosus179 or the  development  of  cancer180.  The  Ripoptosome,  a  2  MDa 
intracelular signaling complex,  was identified  as  one  of the  key  celular  stress  sensors, 
regulating  cel  death  and  survival181.  Genotoxic  stress  as  wel  as the  depletion  of  celular 
inhibitors of apoptosis proteins (cIAPs) can trigger the formation of this multiprotein complex, 
which  contains the  name-giving  RIP1  and associated  proteins  such  as  FADD,  caspase-8, 
RIP3 and cFLIP. Based on the stoichiometric composition and the activity of the respective 
associated  proteins, the  Ripoptosome  can  support  apoptosis,  necroptosis  or  cel 
survival95,144. In this  study, novel  components  of the  Ripoptosome  were identified  and their 
role in  cel  death regulation  as  wel  as in the  propagation  of  non-cel  death  signaling was 
investigated. 
 
IX.1. Spontaneous Ripoptosome formation  and  cel  death induction 
depends on intracelular RIP1 level  
 
RIP1 is one of the key regulators on the crossroad in intracelular cel death and pro-survival 
signaling. Thereby, the dual function of RIP1 is not only carried out during cel homeostasis 
but  also  during fetal  parturition182.  RIP1  knockout  mice displayed  perinatal lethality  due to 
increased apoptosis and necroptosis induced by the innate immune system182. The observed 
phenotype highlighted the indispensable function of RIP1 for the suppression of cel death by 
the  activation  of  pro-survival  genes through  NF-κB,  as  exemplified  during  TNF 
signaling54,151,183. In  contrast,  RIP1  activity can  also lead to  necroptotic  cel  execution  via 
Necrosome formation and RIP3 activation97. Furthermore, RIP1 is the central component of 
the above  described  apoptotic  and  necroptotic  potent  Ripoptosome,  whose formation is 
highly dependent on the intracelular RIP1 level, which are guarded by cIAPs100,144,184. 
Based  on these intriguing findings,  cel  death responses  and  conditions for  Ripoptosome 
formation through RIP1 expression were investigated in HaCaT and HeLa cels. In line with 
previously  published  data95,100,  dramatic  changes in intracelular  RIP1 level resulted in the 
induction of cel death in both cel lines (Figure 7). HaCaT cels showed cel execution mainly 
through apoptosis, since the cel death response was only partialy afected under inhibition 
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of  RIP1  kinase  activity  by  Nec-1.  Additionaly,  necroptosis  could  be  unmasked  by the 
caspase inhibitor  zVAD-fmk (Figure  7B). In  contrast,  HeLa  cels  were  unable to  undergo 
necroptosis,  as  zVAD-fmk  alone  was  able to  block  cel  death  completely (Figure  7D).  The 
phenotype observed in RIP3 deficient HeLa cels was rather expected as recently published 
data  showed that lack  of  RIP3  suppressed  necroptosis induction in  melanoma  and  other 
cancer identities160,185.  Therefore, the  general decreased  sensitivity to  RIP1-induced 
apoptosis  observed in  HeLa  cels  when  compared to  HaCaT (Figure  7B  and  7D)  can  be 
explained  with the  absence  of  RIP3,  as recent  publications  highlighted that  methylation-
dependent loss  of  RIP3 is  a  common  cause for the repression  of  necroptotic  cel  death in 
many cancer identities160,185,186. Another reason for the decreased sensitivity of HeLa cels in 
respect to  apoptosis induced  by  RIP1  overexpression  could  be the  presence  of  cFLIP 
isoforms (Figure  7C),  which in turn  can inhibit  caspase-8  activation  and  activity.  cFLIP 
isoforms were shown to regulate Ripoptosome function and thereby the mode of cel death 
induced by this complex95,100. Heterodimers of the long isoform (cFLIPL) and caspase-8 were 
identified to promote RIP1 cleavage and cel survival95,100. In contrast, caspase-8 and cFLIPS 
dimers favor RIP1  stabilization, resulting in  RIP3  activation  and thereby  necroptotic 
execution95,100.  Absences  of  cFLIP  encourages  caspase-8  homodimerization, thereby 
promoting caspase activation and apoptosis95,100. Summarized, cFLIP is long time known to 
be a potent caspase inhibitor93,117,187, thereby explaining the observed discrepancy in the cel 
death responses seen in HaCaT and HeLa cels (Figure 7B and 7D). On the molecular level, 
uncontroled  and increased  RIP1  expression  or inhibition  of the  direct  negative regulator  of 
RIP1 (cIAPs)  by IAP  antagonists induced the formation  of the  Ripoptosome.  This  could  be 
shown  by the  complex  association  of  RIP1,  FADD,  cFLIP (HeLa)  and  RIP3 (HaCaT)  with 
caspase-8 (Figure 8). In line with former publications, the addition of zVAD-fmk increased the 
formation  of the  caspase-8  containing  complex144. Inhibition  of the  RIP1  kinase  activity  by 
Nec-1 largely suppressed Ripoptosome formation. Tenev and co-workers observed a similar 
efect  when they induced  complex formation  via the  depletion  of  cIAP level  by  Etoposide 
treatment 188. Inhibition  of  RIP1  kinase  activity  by  Nec-1  or  by  overexpression  of  a  kinase 
mutant (RIP1K137A) resulted in  suppression  of  Ripoptosome formation.  Moreover,  Geserick 
and  co-workers  highlighted that  RIP1  kinase  activity is important for the transition  of the 
receptor-bound  CD95  DISC to  a  cytosolic  Ripoptosome-like  complex I  under  conditions 
where  cIAPs  were  depleted87.  Taken together, these findings  highlight the  essential role  of 
RIP1 kinase activity and increased intracelular RIP1 kinase level for Ripoptosome formation. 
It  can  be  speculated that  autophosphorylation  of  RIP1  or the  phosphorylation  of  other 
complex components by RIP1, is important for Ripoptosome stability. 
Interestingly, the  caspase inhibitor  cFLIP  seemed to  be  not required for  RIP1 induced 
complex formation (Figure 8). When HaCaT cels, which harbor very low level of cFLIP, were 
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analyzed after  RIP1  overexpression,  no  changes in  Ripoptosome formation  were  observed 
compared to HeLa cels. Therefore, cFLIP might, as mentioned above, play an essential role 
in the regulation of cel death responses carried out by the Ripoptosome, however, it is not 
required for  Ripoptosome formation  and  association  of the  other  complex  components 
(Figure 8). 
In  contrast to the inhibitory  efect  on  RIP1-induced  complexes, the  above-mentioned  cel 
death responses could only partialy been blocked by the addition of Nec-1 (Figure 7B and 
7D).  On the  contrary,  Tenev  and  co-workers  observed largely reduced  caspase  activation 
upon  Nec-1 treatment in respect to  Etoposide-mediated  cel  death induction144. This could 
not be seen in the here described model system (Figure 7B and 7D). However, both findings 
indicate that  RIP1  kinase  activity is required for  Ripoptosome formation.  As  mentioned 
above,  phosphorylation  events through  RIP1  might  be required for  complex  stability. 
Moreover, the  decreased  amounts  of remaining  complexes  are  stil  suficient to induce  cel 
death (Figure 7B and 7D). Additionaly, cIAP depletion and thereby the Ripoptosome-forming 
potential  of  Etoposides  where  analyzed for a short period time (Figure  17). In  contrast to 
studies from  Tenev188 and  coleagues, treatment  with  Etoposides  showed  no  significant 
induction  of the  Ripoptosome  after  six  hours (Figure  17).  This  discrepancy  might  be 
reasoned by the short incubation (six hours), leading to insuficient depletion of cIAP by the 
Etoposide treatment188.  Therefore, longer  exposure times,  up to twenty-four  hours, have to 
be  used in  order to  observe  substantial  Ripoptosome formation  due to  absence  of  cIAPs 
after Etoposide treatment.  
Nec-1  was  shown to  exhibit  some  of-target  efects, influencing  other  celular  pathways, for 
example  proliferation  of  T-cels  by interfering  with  TCR (T-cel receptor)  signaling189 or the 
suppression  of the immunomodulatory  enzyme indoleamine  2,3-dioxygenase (IDO)158,190. 
Therefore, the observed Nec-1-dependent efects on Ripoptosome formation could likely be 
due to other celular changes despite the inhibition of the RIP1 kinase activity. However, this 
was  mainly ruled  out  by the  usage  of the  specific  RIP1  kinase inhibitor  GSK’481160,  which 
further  validated the  above-mentioned findings.  Ripoptosome formation induced through 
RIP1  expression  was largely  suppressed  by  GSK’481 (Figure  9). In  contrast,  downstream 
inhibition of the necroptotic signaling pathway by the RIP3 inhibitor GSK’840160 had no effect 
on  complex  assembly.  These  data  support indeed  a  model  were  RIP1  kinase  activity is 
required for substantial Ripoptosome formation.  
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IX.2. TBK1, IKK-ε and TRAF2 are novel components of the RIP1-induced 
and TLR3-associated Ripoptosome as wel as TNF complex I 
 
As mentioned above, many recent studies highlighted the important role of Ripoptosome for 
regulation  of  apoptotic  and  necroptotic  cel  death  pathways95,99,144,191.  However,  complex 
composition and downstream signaling was thus far only dissected in terms of already known 
components  of  PCD  pathways,  namely  RIP1,  caspase-8,  FADD,  cFLIP  and  RIP3.  The 
appearance  of  gene regulation, resulting in the production  of interferons  or inflammatory 
cytokines106,107,192 is  a  very  comon  concept after formation  of  multiprotein  complexes. 
Therefore, it is very likely that the Ripoptosome exhibits, besides the regulation of cel death 
programs, similar functional properties. The focus of this study was, therefore, based on the 
identification  of  novel  components involved in  Ripoptosome-mediated signaling.  When 
celular lysates from RIP1 expressing HaCaT cels were size-specific separated on sucrose 
gradients148, the appearance of a high molecular weight complex containing caspase-8 and 
RIP1  was  observed (Figure  10A).  These  data  confirmed that the  overexpression  of  RIP1 
leads to formation  of the  2  MDa  sized  Ripoptosome.  When this  complex  was analyzed by 
mass  spectrometry,  RIP1  and  caspase-8 related  peptides  were found in large  quantities 
(Table  11).  As  stated  above,  FADD has never  been recognized in these  experiments.  This 
could for  example  be  due to the  stoichiometric  composition  of the  Ripoptosome.  As  shown 
for the CD95 DISC signaling, one FADD molecule can bind to several caspase-8 proteins via 
its DED domain193,194. Therefore, one can speculate that one FADD molecule is also able to 
bind  several  portions  of  RIP1  via  DD interactions. Furthermore, RIP1 could assemble in 
amyloid structures, thereby leading to a huge underrepresentation of FADD when compared 
to RIP1 or caspase-8, although FADD is of enormous relevance for the complex formation. In 
contrast,  FADD  was  easily  detected in the  biochemical  complex  analysis  seen in  Figure  8 
and  Figure  9.  Another reason  could  be the  experimental limitations  of the  used  mass 
spectrometric setings. FADD is a rather smal protein of 28 kDA195,196 and depending on the 
used  protease for  peptide  digestion, the  generated  peptides  could  be just too  smal for 
detection197. Most probably a combination of diferent reasons was leading to the absence of 
FADD in the mass spectrometric analysis. 
However, the analysis revealed the rather unexpected association of TBK1, IKK-ε, as wel as 
TRAF2 (Table 11) with the caspase-8-associated RIP1 complexes. This was further verified 
by the  biochemical  analysis  of the  Ripoptosome (Figure  11),  where  al three  components 
could be co-precipitated with caspase-8. Interestingly, the non-canonical IKKs were found to 
be highly phosphorylated and the phosphorylated state was highly enriched in the caspase-
8-associated fractions (displaying the  Ripoptosome).  The  phosphorylation  of  Serine  172 
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displays the classical activation side of the non-canonical IKKs198.  Experimentaly, it is  very 
dificult to  dissect, if the  observed  phosphorylation  occurred in the  cytosol  and the 
phosphorylated protein is recruited to the complex or if the two kinases are phosphorylated 
after complex binding. The ability of both kinases for auto- and transphosphorylation due to 
local  clustering,  would  argue for the later  point136,198,199.  As  shown in  Figure 27, a  high 
quantity of phosphorylated TBK1 is found in the unbound fraction after immunoprecipitation 
although caspase-8 is completely depleted. These findings indicate that there is a free pool 
of  phosphorylated  TBK1, which is  not  bound to the  caspase-8  containing  complex.  This 
argues for the release  of  phosphorylated  TBK1 from the  Ripoptosome  or for the 
phosphorylation of  a free cytosolic TBK1  pool through  other factors.  Moreover, the 
decreased phosphorylation of the non-canonical IKKs correlates with the decreased complex 
formation through the  addition  of  Nec-1.  These results  clearly link  RIP1-induced 
Ripoptosome formation to the phosphorylation of TBK1 and IKK-ε. 
The  activation  of  TLR receptor signaling pathways, in response to  pathogen infections, 
displays a quite common event in the life cycle of multicelular organisms200. During the last 
years, TLR3 receptor stimulation could be linked to celular execution through the association 
of  a  Ripoptosome-like  complex  when  cIAPs  were  depleted100,191,200.  As  described  by 
Feoktistova  and  co-workers, the  combined  stimulation  with IAP  antagonist  and  poly (I:C)-
induced  cel  death in  HaCaT  and  HeLa  cels100 (Figure  12).  Moreover, the  observed 
phenotype was explained by the formation of a TLR3-associated Ripoptosome, as described 
before100. Of note, stimulation with IAP antagonist (data not shown) or poly (I:C) alone was 
not  suficient to induce  cel  death100. In line  with  TNF receptor signaling and  complex I 
formation, stimulation of the TL3 receptor by poly (I:C) is primary leading to gene induction 
via NF-κB or IRF380,201. First the recruitment of the IAP antagonist-induced Ripoptosome to 
the TLR3 receptor enables for cel death induction, as observed for TNF complex I80,100,188. In 
summary, that  means that the receptor-associated  Ripoptosome  converts  pro-inflammatory 
cytokines into  prodeath  signals188. This  could  have important impact  on the  design  of 
anticancer therapies, utilizing  cancer-related inflammation.  Given that  Ripoptosome 
formation  sensitizes  cels to  cytokines  such  as  TNF  and  poly (I:C), it  seems likely that 
therapeutic strategies designed to boost Ripoptosome assembly wil help to convert cancer-
related proinflammatory signals into pro-death stimuli188. 
Interestingly,  when the  TLR3-bound  complexes  were  analyzed for the  newly identified 
components, the three novel proteins; TBK1, IKK-ε and TRAF2 were al coprecipitated with 
caspase-8 (Figure 13). This was also true when Jurkat cels were tested for IAP antagonist 
together  with  poly (I:C)-induced  complex formation (Figure  14).  These findings argue for  a 
general integration of the three proteins into Ripoptosome-like complexes. The stoichiometric 
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composition  of the  TLR3-associated  complex  undergoes time-dependent  changes (Figure 
13).  The three  novel  components reach their  maximum  of  complex  association  at  a rather 
early point of time and become released over time. This data could explain why the above-
mentioned free pool of phospho-TBK1 was observed in the unbound fraction (Figure 27). 
It is long time  known that  RIP1-association  with the  TLR3  adaptor  TRIF  via  RHIM  domain 
interactions is required for TLR3-dependent NF-κB activation202,203. During the last years, the 
impact  of  RIP1 in  TLR3-associated  Ripoptosome formation  and  cel  death induction  was 
highlighted100. The partial elimination of RIP1 by siRNA or shRNA mediated knockdown, was 
able to  block  cel  death  and  decrease IAP  antagonist  and  poly (I:C)-induced  complex 
formation. In order to further clarify the role of RIP1 for poly (I:C) and IAP antagonist-induced 
Ripoptosome signaling, HeLa RIP1 knockout cels were generated using the CRISPR/Cas9 
system. The  CRISPR/Cas9 technology revolutionized the  scientific landscape through the 
last years. It provided a tool for any kind of fast and easy genetic manipulations204, including 
complete  genetic  knockouts.  However,  of-target  efects  are  a  common  event  of the 
CRISPR/Cas9  system,  creating  unspecific  genetic  alterations in  unexpected  DNA 
regions205,206. Furthermore, selection of single cel clones in order to generate homogenic cel 
lines  can result in the favoritisms of  cels  with  unwanted  genetic  side  efects207. In  order to 
circumvent this problem, at last two knockout clones were used in the folowing analysis. 
In line  with the  RIP1  knockdown  experiments,  CRISPR/Cas9  mediated  RIP1  knockout 
resulted in total inhibition of cel death execution by poly (I:C) in the absence of cIAPs (Figure 
15).  Not  surprising,  TLR3-associated  Ripoptosome formation  was  completely inhibited  with 
the loss  of  RIP1 (Figure  16).  Remarkably, the  phosphorylation  of  TBK1  upon poly (I:C) 
treatment  was  not impaired (Figure  16,  TL  samples),  but  association  with  caspase-8  was 
fuly blocked. These data support the published findings that activation of TBK1 and further 
propagation  of the IRF3  pathway in respect to  TLR3  activation is not  dependent  on 
RIP1105,172,208.  Taken together, these  data  support  a  model  where  depletion  of  celular IAP 
level leads to the association of RIP1 and FADD via their DD domains. This leads to further 
binding of caspase-8 to FADD via their DED domains, finaly forming the Ripoptosome and 
enabling the  complex for  cel  death induction.  When the  TLR3 receptor is in  addition 
stimulated, the binding of TRIF to the cytosolic part of the receptor starts the recruitment of 
the  Ripoptosome to the  TLR3 receptor  by  RHIM interactions  between  RIP1  and  TRIF.  The 
novel identified proteins TBK1, IKK-ε and TRAF2 might now be recruited via other domains 
of RIP1, e.g. the death domain, into the Ripoptosome. Another possibility is that recruitment 
of FADD or caspase-8 triggers the association of these novel components into the complex. 
However, the exact binding sites and how these proteins are recruited to the complex remain 
to be elucidated. 
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Binding of TNF to its specific receptor is long time known to induce gene expression, leading 
to inflammatory responses73,116.  Thus,  deregulations in  TNF receptor signaling is linked to 
many inflammatory  diseases including  Crohn’s  disease  and rheumatoid  athritis209–211. 
Furthermore, TNF plays a pivotal role in cancer development and progression. Tumor cels 
were found to  constitutively  express  and  secrete low levels  of  TNF, thereby leading to the 
constant  NF-κB-dependent  expression  of  anti-apoptotic  and  pro-survival  genes73,212. 
However, many studies highlighted that cIAP depletion plus TNF stimulation can, similar to 
the TLR3-associated complex, lead to the formation of the so caled TNF complex I, which 
harbors the ability to induce apoptosis and necroptosis80,81. Therefore, complex I formation 
and cel death induction could be used as a potential target for cancer therapies213. On the 
molecular level, the Ripoptosome and TNF complex I incorporate identical components and 
are  both  able to induce  cel  death  based  on the  stoichiometric  composition.  The 
Ripoptosome  can form independent  of  death receptor  stimulation  by  TNF through the 
depletion  of  cIAPs100,144. In  contrast,  TNF  complex I relies  on  TNF  stimulation  and the 
transition  of the receptor-bound  complex I to the  cytosolic  complex I80.  Another  diference 
was  made  by the  modification  status  of  RIP1.  Ripoptosome formation incorporates 
unmodified RIP1 due to the lack of cIAPs214 whereas TNF complex I harbors CYLD-modified 
RIP1 from complex I215. 
However,  based  on the findings in this  study  diferences  between  TNF  complex I,  TLR3-
associated and RIP1-induced Ripoptosome could not be identified. When HaCaT cels were 
stimulated  with IAP  antagonist  and  TNF-HF in the  presence  of  zVAD-fmk for  six  hours, 
substantial association of caspase-8 with complex I components RIP1, FADD and TRADD 
was observed. Interestingly, presence of the TNF complex adaptor TRADD was observed in 
the  TLR3-associated  complex (Figure  17),  although it is  a  classical  compound  of the  TNF 
complex  signaling pathway165.  TRADD  binds to the intracelular  part  of  activated  TNF 
receptor to  enable the formation  of the intracelular signaling complex I.  Moreover,  TRADD 
was shown to bind TRAF2 thereby promoting the association of cIAPs, which are responsible 
for RIP1 modifications in TNF complex I76,77,166. However, TRADD was also reported to play a 
role in  TLR3  mediated  gene induction  as  wel  as  poly (I:C)-mediated toxicity in MEFs165,166. 
With the  above-mentioned findings,  one  can  now  speculate that influence  of  TRADD  on 
TLR3-mediated signaling is  due to the  association  with the  TLR3-bound  Ripoptosome. 
Furthermore, the data suggest TRADD as a general member of Ripoptosome-like signaling 
complexes. Interestingly, in addition to TRADD, the novel identified components; TBK1, IKK-
ε and TRAF2 were also found to be part of the precipitated TNF complex I. These findings 
additionaly confirm that Ripoptosome-like complexes harbor the integral components TBK1, 
IKK-ε, TRAF2 and TRADD. 
Discussion 
77 
IX.3. TRAF2  but  not  TBK1  and IKK-ε inhibits  apoptotic  cels  death  upon 
RIP1 overexpression 
 
The E3 ubiquitin-ligase TRAF2 is long known as an important member of the TNF complex I 
signaling complex  and  an important  apoptosis inhibitor in  TNF  signaling80,168,216.  TRAF2 is 
also responsible for the association of cIAPs in order to modify RIP1, thereby enabling NF-κB 
activation  and finaly  expression  of  anti-apoptotic  proteins217,218.  Moreover, recent reports 
highlighted the  additional inhibitory  efect  of  TRAF2 in  TNF-,  CD95L- and  TRAIL-mediated 
necroptosis169,170. However, TRAF2 has thus far not been linked to Ripoptosome formation. 
In this  study  siRNA  mediated  knockdown  of  TRAF2 (Figure  18A  and  18B) resulted in 
increased  apoptotic  cel  death,  unmasked  by  Nec-1 treatment  after  RIP1  overexpression 
(Figure  18C),  supporting the  anti-apoptotic  efect  of  TRAF2. It is  very intuitive that  TRAF2 
might, similar to the function in TNF complex I signaling, induce the binding of cIAPs to the 
Ripoptosome.  This  would  enable the  cIAPs to  modify  RIP1, thereby leading  either to 
disassembly  of the  complex  by the  degradation  of  RIP1  or the induction  of  other signaling 
pathways like  NF-κB  and the  expression  of  anti-apoptotic factors. In  contrast, the reported 
inhibitory  efect  of  TRAF2  on  necroptosis169,170 was  not  observed.  When  cels  were treated 
with the caspase inhibitor zVAD-fmk, folowed by overexpression of RIP1, no diferences in 
necroptotic cel death responses were observed between the control cel line and the TRAF2 
knockdown (Figure  18C). It  might  be that the  necroptotic responses  due to  RIP1-induced 
Ripoptosome formation behave diferently when compared to the reported efects after death 
receptor stimulation through TNF, CD95L or TRAIL. 
The surprising finding of the non-canonical IKKs (TBK1 and IKK-ε) as novel components of 
the  Ripoptosome  encouraged the  examination  of  both  kinases in respect to  cel  death 
induction.  TBK1  and IKK-ε  are  very  wel  established  key regulators  of the innate immune 
system133,198.  Moreover, recent reports  highlighted  TBK1  as  an inhibitor  of  TNF-induced 
apoptosis  by the induction  of  anti-apoptotic  gene  products175. In this  study,  we therefore 
tested the influence of TBK1 and IKK-ε on cel death responses induced by the expression of 
RIP1.  When  both  kinases  were  knocked  down  by  siRNA (Figure  18B,  19A  and  19B),  no 
significant  changes in  PCD responses  were  observed (Figure  19C).  Therefore, the  anti-
apoptotic  efect  could  not  be  verified in respect to  RIP1  expression.  However,  here,  as 
described above for TRAF2, the formation of the RIP1-induced Ripoptosome could display a 
total  diferent  scenario than  TNF  stimulation. In the reported  seting,  TBK1  could  very  wel 
exhibit gene inductive properties in TNF complex I, thereby leading to the expression of anti-
apoptotic proteins, whereas in the RIP1-induced situation there is no gene induction carried 
out  by complex I. Summarized,  our  analysis identified  an inhibitory function for  TRAF2  on 
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RIP1-induced  apoptosis  whereas the  necroptotic response  was  unaltered.  TBK1  and IKK-ε 
seemed to have no obvious influence on PCD signaling in the RIP1 overexpression system. 
 
IX.4. Ripoptosome formation in  TLR3-signaling is IKK-ε- and  TRAF2-
independent, but TBK1 modulates complex stoichiometry 
 
Many  proteins including  FADD  and  caspase-8  can fulfil  scafolding functions in  specific 
signaling complexes  or  pathways196,219,220.  Ripoptosome  composition  or  stoichiometry  or 
activity  of  other  complex-associated  proteins  might, therefore, be influenced  by the lack  of 
TBK1, IKK-ε and TRAF2. Genetic knockouts of al three components in HeLa cels, including 
the  TBK1/IKK-ε  double  knockout,  were generated  and  analyzed for  changes in  complex 
composition.  Therefore, the  double  knockout  of  TBK1  and IKK-ε  was  generated in both 
directions to rule  out  of-target  efects (TBK1  knockout  cel line transfected  with the IKK-ε 
CRISPR  and  vice  versa).  When analyzed for the  expression  of  PCD involved  proteins,  no 
efects on complex-related protein expression was observed (Figure 20). Cel death caused 
by the  combined treatment  of IAP  antagonist  and  poly (I:C)  was  not  altered  by the  double 
knockout  of  TBK1  and IKK-ε.  These  data  confirmed the  above-mentioned  knockdown 
experiments, again showing that TBK1 and IKK-ε have no direct influence on Ripoptosome-
mediated cel death signaling. In contrast, the TRAF2 knockout showed in line with the above 
described  data for  RIP1  expression,  a sensitization against IAP  antagonist  plus  poly (I:C) 
treatment (Figure  21).  Therefore, TRAF2  could  be identified  as  an inhibitor  of  programmed 
cel  death through  RIP1- or IAP  antagonist  plus  poly (I:C)-induced  Ripoptosome formation. 
The inhibitory function  might  most  probably  be carried  out  by  suppression  of  anti-apoptotic 
gene expression, which was already reported for TNF, CD95 and TRAIL treatment169,170,216. 
When complex formation was analyzed in the knockout cels, TLR3-associated Ripoptosome 
formation  could  be  observed in  al  cel lines.  Loss  of IKK-ε  and  TRAF2  did  not  alter the 
complex formation  when  compared to the  control  cels (Figure  22A  and  22B). Interestingly, 
the lack of TBK1 resulted in a changed stoichiometry of the Ripoptosome. RIP1, FADD and 
cFLIP  showed  a  decreased  association  with  caspase-8-associated  RIP1  complexes, 
whereas levels  of IKK-ε  or  TRADD  were  not  afected. In turn,  TRAF2  seemed to  be 
increased in the formed Ripoptosome when TBK1 was not present. Interestingly, TRAF2 was 
shown to form  a  complex  with  TANK (TRAF family  member-associated  NF-kappa-B 
activator) and TBK1, resulting in TBK1 activation and finaly NF-κB induction221–223. One can 
now  speculate that  both  proteins  carry  out  a  similar function in  Ripoptosome signaling. 
Complex formation  could  bring  TRAF2  and  TBK1 into  close  proximity,  which  enabled the 
Discussion 
79 
TRAF2-dependent activation of TBK1, resulting in the final activation of NF-κB. The observed 
enrichment  of  TRAF2 in the  Ripoptosome (formed in the  TBK1  knockout  cel lines) could 
display a compensatory mechanism, as the postulated TBK1/TRAF2 pathway was abolished. 
TBK1 activation by TRAF2 could result in the release of TRAF2 from the complex, therefore, 
explaining the increased  TRFA2 level in the  TBK1  knockout  cels.  An interesting further 
question in this respect  would  be if  TANK could also  be found  associated  with the 
Ripoptosome.  However, lack  of  TBK1  seemed to influence  caspase-8  association  of  many 
diferent complex components (RIP1, FADD, cFLIP). Therefore, it might also be possible that 
TBK1 exhibits a scafolding function for regulated complex assembly. The knockout situation 
might  now result in  unregulated  or  unstable  association  of the  Ripoptosome  components 
thereby explaining the seen diferences in single factors. Of note, cel death responses were 
unaltered  after the  TBK1  knockout (Figure  21),  meaning that the  changes in  complex 
composition do not afect the Ripoptosome-mediated cel death responses. However, further 
analyses have to be made to clarify the role of TBK1 in respect to Ripoptosome formation.  
As stated above, the CRISPR/Cas9 system as wel as the single cel selection process could 
result in diferent genetic alterations. This could be seen, as the described TBK1-dependent 
efect on complex composition was not observed in the IKK-ε/TBK1 double knockout in the 
second  set  of  clones (Figure  22B, IKK/TBK  KO),  although the  knockout  and  basal  protein 
expression  showed  no  diferences.  The  mentioned  clone  could  have  alterations in  other 
proteins (not analyzed in these experiments) that act downstream of the Ripoptosome/TBK1 
axis, thereby  enabling the  compensation  of the  TBK1 loss.  Altogether, the results  created 
with  CRISPR/Cas9  mediated  knockout  cels  should  be interpreted  very  criticaly  and 
validated through additional methods, as the role of TBK1 for TLR3-associated Ripoptosome 
formation could not conclusively be verified from the observed data. However, as three out of 
four  clones  showed  similar  alterations  after  TBK1 loss, it is rather likely that the  observed 
changes where due to the absence of TBK1. 
 
IX.5. Ripoptosome formation induces  phosphorylation  of  NF-κB 
inhibitors, resulting in  TBK1- and IKK-ε-dependent target  gene 
expression 
 
From the generated data, TBK1 and IKK-ε could be identified as Ripoptosome components 
not involved in complex-dependent cel death signaling pathways. As mentioned-above and 
further  encouraged  by the  enriched  association  of  TRAF2 in the  complex when  TBK1 is 
absent,  Ripoptosome formation  might  very likely induce  gene  expression.  This  might  be 
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carried  out  by the activation  of the  NF-κB  pathway  or  other transcriptional  activators in  a 
TBK1- and IKK-ε-dependent  manner.  Time-dependent  kinetics  of  RIP1  expression  or IAP 
antagonist plus poly (I:C) treatment indeed showed stimulation-dependent phosphorylation of 
the NF-κB inhibitor IκB-α (Figure 23A and 23B), which is a long known indicator for canonical 
NF-κB activation112,224. In contrast, phosphorylation of the NF-κB protein p65 (RelA) at Serine 
536  was  diferentialy regulated  during  RIP1  expression  and IAP  antagonist  plus  poly (I:C) 
treatment. Interestingly, it  was  shown that this regulatory  NF-κB  subunit  can  be  activated 
independently  of IκB-α  degradation  and induce  a  specific  subset  of target  genes, including 
the inflammatory cytokine interleukin-8 (IL-8)225–227. Furthermore, IKK-ε was shown to directly 
target  p65 for  phosphorylation  after  TNF  stimulation228.  Under  expression  of  RIP1, 
phosphorylation of p65 was increased over time in line with the increasing phosphorylation of 
the non-canonical IKKs as wel as MLKL, indicating Ripoptosome formation and necroptosis 
induction (Figure  23A).  One  may  now  envision that the  RIP1-induced  complex formation 
could lead to the  phosphorylation  of  p65 in  an IKK-ε-dependent  manner. Moreover, IκB-α 
was  phosphorylated  over time, in line  with increasing  RIP1 level. In total, the data  clearly 
show that increased  RIP1 expression leads to the  activation  of the NF-κB  pathways. In 
contrast, treatment with IAP antagonist and poly (I:C) resulted in early p65 phosphorylation, 
which was lost over time (Figure 23B). Additionaly, phosphorylation state of TBK1 and IKK-ε 
was increased at early points of time, but did not change with increasing incubation time. It is 
known that  poly (I:C)  binding to the  TLR3 receptor induces  NF-κB responses,  which  are 
propagated via TRAF6 and a TAK/TAB complex107,201, explaining the early seen activation of 
p65 and phosphorylation of IκB-α. Additionaly, poly (I:C) stimulation is known to result in the 
activation of the transcription factor IRF3105,136,138. This was also observed in our experiments 
(Figure  22B),  giving the reason for the rapid  phosphorylation  of  TBK1  and IKK-ε. 
Furthermore, the non-canonical NF-κB pathway was activated after IAP antagonist and poly 
(I:C) treatment,  as  shown  by the  cleavage  of  NF-κB  p100  precursor into the  active  p52 
fragment. This activation was rather expected as depletion of cIAPs is known to stabilize the 
NF-κB inducing  kinase  NIK, thereby  activating the  non-canonical  NF-κB  pathway123,125. 
Taken together, IAP antagonist and poly (I:C) treatment display a rather complicated system 
to  study  NF-κB  activation in respect to  Ripoptosome formation.  Treatment  with  poly (I:C) 
alone is suficient to induce NF-κB after the recruitment of a TRAF6/TAK/TAB complex to the 
receptor-bound TRIF (Figure 5)107,201. This complex can then target the IKK complex, finaly 
leading to IκB-α degradation. In  paralel, TBK1/IKK-ε are recruited to TRIF to activate IRF3 
105,106,229. Moreover, depletion of cIAPs by IAP antagonists result in the activation of the non-
canonical NF-κB pathway by stabilization of NIK123,125. Finaly, poly (I:C) and IAP antagonist 
treatment results in the recruitment of the  Ripoptosome to the  TLR3 receptor, further 
increasing the  NF-κB response  as  seen through the  RIP1 induction (Figure  5).  Therefore, 
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many  diferent independent  pathways  are  switched  on  by  poly (I:C)  and the  depletion  of 
cIAPs, making it dificult to discriminate between TLR3-dependent and Ripoptosome-induced 
signaling.  The  overexpression  of  RIP1  also resulted in the induction  of  NF-κB (Figure  23), 
although the expression  of  RIP1  kinase  displayed  a  single trigger for the  observed 
modifications of NF-κB components and activators. Therefore, gene expression analyses in 
this study, were based on the expression of RIP1, as NF-κB induction was clearly visible in 
this system in line with increasing RIP1 level. 
As  mentioned  above, p65  phosphorylation is  an indication for induction  of inflammatory 
genes  especialy IL-8226,230.  Gene  expression  analysis  after  RIP1 induction indeed revealed 
an  up to  100 fold induction  of IL-8 mRNA (Figure  24A).  As  described  by  Kavuri  and 
coleagues117, the addition  of the  caspase inhibitor  zVAD-fmk further increased this  mRNA 
expression. Interestingly, inhibition  of the  kinase  activity  of  RIP1  by  Nec-1  decreased IL-8 
expression, especialy seen for the six-hour incubation time (Figure 24A). As shown by the 
previous  data (Figure  8)  Nec-1 inhibits  RIP1-induced  Ripoptosome formation,  arguing for 
complex dependency of the observed gene induction. The described results were also true 
for the anti-apoptotic gene SERPINB2 (Figure 24B). Expression of SERPINB2 was shown to 
be dependent on TBK1-mediated phosphorylation of p65 after TNF stimulation175, displaying 
expression  of  specific  activation  of  a  subset  of  NF-κB target  genes.  These  data  might link 
Ripoptosome-mediated  gene induction to the  observed  association  and  activation  of  TBK1 
with the complex. This hypothesis was further verified when TBK1/IKK-ε double knockdown 
was  assessed for IL-8 mRNA  expression.  Compared to the  control  cels, the  absence  of 
TBK-1 and IKK-ε reduced IL-8 expression of about 25%, indicating a direct influence of both 
proteins for  complex  mediated  gene  expression.  Micro  Array  analysis  of the whole  mRNA 
expression identified that increased RIP1 levels influenced not only IL-8, but also altered the 
expression  of  diferent  chemokines involved inflammatory responses (Table  12).  Especialy 
the expression  of CXCL-1 and CCL-20, two  NF-κB target  genes,  were induced upon 
increased  RIP1  expression.  Both  cytokines were  shown to  be  classicaly  upregulated in 
inflammatory diseases231,232. Furthermore, the expression of CXCL-1 and CCL-20 was found 
after cytokine stimulation, including CD95L treatment and pathogen infection91,231–234. In line 
with the IL-8 data, the reduction of TBK1 and IKK-ε protein level resulted in the suppression 
of  both cytokines. In  contrast, the expression  of SERPINB2 was  not  substantialy  changed 
under TBK1 and IKK-ε knockdown conditions. This might argue for a diferent regulation of 
this  particular  anti-apoptotic  gene  during  Ripoptosome formation  when  compared to  TNF 
stimulation. The use of siRNA-mediated knockdown could also explain the absent efect on 
SERPINB2, as litle amounts of TBK1 could stil be suficient to fulfil the p65 phosphorylation 
needed for SERPINB2 induction.  Altogether, the  observed  patern  of regulated  genes  after 
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RIP1 overexpression displayed a common NF-κB signature, finaly resulting in inflammatory 
and pro-survival responses, which are often seen after celular stress stimuli. 
Altogether, these  data linked  Ripoptosome formation to  NF-κB-mediated  gene  expression 
involved in inflammatory responses. Similar results were reported for other RIP1 containing 
complexes, like TNF complex I or CD95 DISC complex I54,116,233. Altogether, RIP1 complex 
association, especialy in the  Ripoptosome  seems to interconnect  cel  death-inducing 
signaling complexes to  NF-κB-dependent  gene induction.  Furthermore,  gene  expression  of 
several inflammatory genes was decreased by the reduction of TBK1 and IKK-ε protein level, 
supporting the idea that  complex-associated  TBK1  and IKK-ε function  as regulators for  a 
subset  of  NF-κB target  genes.  However,  downstream targets  of  both  kinases remain to  be 
elusive,  although  p65  was  shown to  be  phosphorylated  by  both  kinases175,225,226 and 
therefore, displays a promising target.  
 
IX.6. Overexpression  of RIP1 induces  TBK1- and IKK-ε-dependent 
phosphorylation of autophagy receptors 
 
Recent studies highlighted the pivotal role of TBK1 for autophagic or especialy mitophagic 
clearance during stress signaling141,143.  As  stated  above,  Ripoptosome formation  displays  a 
celular  stress response  due to  changes in  RIP1 level.  Therefore,  one  can  speculate that 
there is  a  crosstalk  between  Ripoptosome formation  and  autophagy induction.  HeLa 
TBK1/IKK-ε  double  knockout  cels  showed, in line  with the  above  described  poly (I:C) 
treatment,  no  alteration in their  cel  death response induced  by  RIP1  expression  when 
compared to  control  cels (Figure  26B).  Ripoptosome formation  was  also  unaltered  by the 
loss  of  TBK1  and IKK-ε (Figure 27).  However,  when  phosphorylation  sites  of the  whole 
celular extracts after RIP1 expression were compared to control cels, significant changes in 
the phosphorylation status of diferent proteins were observed (Table 13).  
Interestingly, the  autophagy inducing  proteins  optineurin  and  sequestosome-1  were 
phosphorylated  upon  RIP1  expression in  a  TBK1- and IKK-ε-dependent  manner.  Of  note, 
both proteins were shown to physicaly interact with TBK1 for example during the clearance 
of damaged mitochondria143. Optineurin modification on Serine 177 was shown to be TBK1-
dependent and responsible for the recruitment of ATG8 (autophagy related protein-8), which 
is required for  autophagosome formation62,143,235. In  contrast, Serine  120  phosphorylation is 
thus far  not  described for  optineurin,  displaying  a  possible  novel target  site for  autophagy 
induction.  One  can  also  speculate that this  specific  site is targeted by IKK-ε for 
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complementary  autophagic  activation in line  with  TBK1  Serine  177  phosphorylation. 
Additionaly, the autophagy cargo protein sequestosome-1 was found to be phosphorylated 
at  Serine  282  and  366 in  a  TBK1- and IKK-ε-dependent  manner141,198.  Sequestosome-1 
classicaly recognizes toxic celular waste and targets it for autophagic clearance236. Pili and 
coleagues identified TBK1 as the kinase that targets sequestosome-1 on Serine 403 during 
microbial infections, thereby  enabling  autophagosome  maturation141. In  contrast, the 
identified TBK1- and IKK-ε-dependent phosphorylation sites were not characterized thus far. 
Moreover,  sequestosome-1  was  shown to interact  with  RIP1 for the  activation  of  NF-κB237. 
Therefore, sequestosome-1 might also bind to Ripoptosome-bound RIP1 and might then be 
targeted  by  TBK1  or IKK-ε to induce  NF-κB. Interestingly, the  activation  of  autophagy  was 
shown to exhibit dual functions in respect to tumor progression and cel death resistance in 
cancer  cels.  The tumor  suppressor function is  mainly linked to the  ability to  prevent the 
accumulation of toxic oxygen radicals by scavenging damaged oxidative organeles238,239. In 
contrast,  autophagy  was  shown to  be  upregulated in  many  cancer identities,  where it 
promotes  cel  survival  and  cel  death resistances240.  The tumor  promotor function  of 
autophagy  was  proposed to  be  one  critical reason for the  development  of  secondary 
resistances  after  modern  drug  based  cancer therapies like  RAF (rapidly accelerated 
fibrosarcoma) inhibition in melanoma treatment241. Drug based inhibition of celular pathways, 
like treatment  with  PI3K (Phosphoinositid-3-Kinasen) inhibitors,  can  mimic  starvation 
conditions, thereby promoting the autophagic recycling of intracelular components and finaly 
cel  survival242. It  can  be  hypothesized that the  observed  phosphorylation  of  autophagy 
receptors after Ripoptosome formation could be a similar survival mechanism. As mentioned 
above, formation  of the  Ripoptosome is  a  celular  stress  sensor to  diferent  extrinsic  and 
intrinsic  stimuli,  which  harbors the  ability to induce  programmed  cel  death.  The  paralel 
induction  of  autophagy  could  now  act  as  a  surveilance  system, trying to  maintain  cel 
viability.  However, further  analyses  have to  be  made  and  mutations  of the  single 
phosphorylation  sites  are required to finaly  clarify their role  and impact  of  autophagy 
induction in Ripoptosome-mediated signaling. 
Additionaly, the phosphorylation status of Ripoptosome components RIP1 and TRAF2 were 
altered in a TBK1- and IKK-ε-dependent manner. The identified RIP1 phosphorylation sites 
were thus far not identified as functional RIP1 modifications243,244. However, these sites could 
very  wel  display  novel regulatory  elements involved in  Ripoptosome-mediated  RIP1 
signaling. In the  case  of  TRAF2,  phosphorylation  at  Serine  11 is  a  wel  described 
modification,  which is responsible for the  anti-apoptotic function  and  gene inductive 
properties of TRAF2245,246. In contrast, phosphorylation on Serine 7 is thus far not described. 
These  data  support the  above-mentioned idea that  TRAF2  association  and  apoptosis 
inhibition  during  Ripoptosome formation is  most likely  carried  out  by the induction  of  anti-
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apoptotic genes. Interestingly, the therefore necessary phosphorylation seems to be carried 
out by the associated kinases TBK1 and IKK-ε. Moreover, the phosphorylation status of the 
NF-κB inducing protein TAB2247 was changed by loss of the non-canonical IKKs. Altogether 
these results  might  explain  how  and  why the loss  of  TBK1  and IKK-ε result in reduced 
expression  of  NF-κB target  genes,  although further  studies  wil  be  needed to  validate  and 
dissect the function of both kinases in this respect.  
Summarized, the  data  presented in this  study  promote the in  Figure  28  described 
Ripoptosome  model.  Genotoxic  stress  or  chemical  compound-mediated  depletion  of the 
celular IAP level results in  a  changed  balance  of the  celular  RIP1  equilibrium.  The 
increasing  pool  of  active  and free  RIP1  promotes the formation  of the  Ripoptosome, 
containing the  proteins  RIP1,  caspase-8,  FADD,  cFLIP  and the  novel identified  proteins 
TRADD, TRAF2, TBK1 and IKK-ε. Furthermore, the combination of cIAP depletion together 
with  death receptor  activation  or  stimulation  of the  TLR3 receptor  can  promote recruitment 
and  accumulation  of the  Ripoptosome to the respective receptors.  Based  on the  complex 
stoichiometry, especialy the portion of associated cFLIP, formation of this signaling platform 
can lead to apoptotic cel execution by caspase-8 activation or necroptotic cel death through 
activation  of the  RIP1/RIP3  axis. In this  study, TRAF2  was identified  as a  novel  complex 
component, influencing the apoptotic cel death response upon Ripoptosome formation. The 
anti-apoptotic function of TRAF2 might very wel be carried out, similar to the TNF complex, 
through  activation  of  anti-apoptotic  gene  expression167,218,221. The  binding  of  TRAF2 to the 
Ripoptosome  might  be  dependent on TRADD,  which  was  also found to  be  a part  of the 
Ripoptosome-like  complexes in this  study.  TRADD  was  shown to  directly interact  with 
TRAF276,168 in order to facilitate RIP1 modifications through cIAPs in TNF complex signaling. 
Therefore, both  proteins  might  execute  similar functions in the  Ripoptosome as in  TNF 
signaling. However, further studies have to be made in order to dissect whether TRAF2 realy 
bind via TRADD to the complex and if loss of TRAF2 inhibits induction of anti-apoptotic gene 
products after Ripoptosome formation. In addition, the non-canonical IKKs, TBK1 and IKK-ε 
were found to  be integral  parts  of  TNF  complex I  and the  RIP1- and  poly (I:C)-induced 
Ripoptosome. However, loss of both proteins had no efect on Ripoptosome-mediated PCD 
execution. In paralel to cel death induction, gene expression of inflammatory cytokines was 
increased via the activation of NF-κB after complex formation. As previously described, the 
induction  of  a  subset  of inflammatory  NF-κB target  genes  was  dependent  on the  kinases 
TBK1 and IKK-ε. The phosphorylation of p65 might be a possible target of both kinases, as 
similar functions were reported before in case of TNF receptor signaling175. However, if NF-
κB  activation  after  Ripoptosome is  diferentially regulated  by  both  kinases  or if they 
complement each other, stil has to be clarified. 
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Additionaly, phosphorylation state of diferent proteins was dramaticaly changed depending 
on  TBK1  and IKK-ε  after the  expression  of  RIP1. Interestingly,  autophagic receptors 
optineurin and sequestosome-1 were diferentialy modified at several sites after the lack of 
TBK1  and IKK-ε.  These findings  might link  Ripoptosome formation  and the  activity  of the 
diferent molecules within this complex to autophagy regulation, displaying a novel pathway 
that is regulated  by this signaling complex.  However, the physiological  appearance  of 
autophagy  stil  needs to  be tested.  Additionaly, the function of the  newly identified 
phosphosites needs to be elucidated in order to clarify their role for cel death regulation or 
non-cel  death linked  pathways.  Altogether, this  study  highlighted  novel  components  and 
signaling pathways that  are influenced  after  Ripoptosome formation.  The  beter 
understanding  of  Ripoptosome-mediated signaling might  ofer  novel ideas for target tumor 
therapies,  as the  complex is  predominantly formed in  cancer  cels  but  not in  primary 
cels100,188,248. A  combined treatment  of tumor patients  with  Smac mimetics  and 
chemotherapy is currently under clinical trials, as many cancer identities including ALL (acute 
lymphoblastic leukemia) can  be  sensitized to  celular  execution  by  promoting  Ripoptosome 
assembly249,250. In contrast, chronic lymphocytic leukemia (CLL) was shown to be resistant to 
Smac mimetic treatment as these  cels  were  unable to form  a  Ripoptosome147. It  can  be 
speculated that targeted  suppression  of the  here identified  Ripoptosome-mediated  non-cel 
death signaling pathways (NF-κB  and  autophagy),  could  display  novel  mechanisms further 
accelerating  Ripoptosome-induced  cel  death.  As  mentioned  above, autophagy inhibition 
might  display  a  novel  strategy to  overcome  secondary resistances in tumor growth. 
Therefore,  Smac mimetic treatment  combined  with  autophagy inhibition  could  sensitize 
resistant tumor cels to  cel  death.  Furthermore,  direct  modulation  of the  newly identified 
components  TBK1, IKK-ε  or  TRAF2  might provide  novel Ripoptosome  signaling-mediated 
therapy  approaches.  Especialy, the inhibition  of  TRAF2  could favor celular  execution in 
resistant  cancer  cels,  as  decreased  TRAF2 level  were  sensitizing to  death receptor  and 
TLR3-mediated  PCD169,170.  Hence, the  beter  understanding  and  characterization  of these 
novel  components  and  signaling  pathways  might  be important for the  development  and 
improvement of specialized, targeted cancer therapies or disease treatments. 
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XI. Abbreviations 
 
%  Percent 
°C  Degree Celsius 
4-HT 4-Hydroxytamoxifen 
AIF Apoptosis inducing factor 
Apaf-1  Apoptotic protease activation factor 1 
ATG Autophagy related protein 
Bak Bcl-2 antagonist or kiler 
Bax Bcl-2-like protein 4 
Bax Bcl-2-associated X protein 
Bcl-2 B-cel lymphoma 2 
BH3 Bcl-2 homology 3 
Bid BH3 interacting-domain death agonist 
Bid BH3 interacting-domain death agonist 
CARD Caspase recruiting domain 
caspases Cystein-aspartatic proteases  
CCL-20 Chemokine (C-C motif) ligand 20 
CD95 Cluster of diferentiation 95 
CD95L CD95 ligand 
cFLIP Celular FLICE-like inhibitory protein 
cIAPs Celular inhibitor of apoptosis proteins 
Ctrl Control 
CXCL-1 chemokine (C-X-C motif) ligand 1 
DD Death domain 
DED Death efector domain 
Diablo  Direct IAP binding protein with low pI 
DISC Death inducing signaling complex 
DL Death ligand 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleoside triphosphate 
DR Death receptor 
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
FADD Fas-associated protein with death domain 
FCS Fetal calf serum 
FLICE FADD-like IL-1β-converting enzyme 
g Gram 
GAPDH Glyceraldehyde 3-phosophate dehydrogenase 
h Hour 
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Hepes 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
HLH Helix-loop-helix  
IFN Interferon 
IKK IκB kinase 
IKK-α Inhibitor of nuclear factor kappa-B kinase subunit alpha 
IKK-β Inhibitor of nuclear factor kappa-B kinase subunit beta 
IKK-ε Inhibitor of nuclear factor kappa-B kinase subunit epsilon 
IL-8 Interleukin-8 
IMS Intermembrane space 
IP Immunoprecipitation 
IRF-3 Interferon regulatory factor 3 
IκB-α Inhibitor of kappa B-alpha 
KD Kinase domain 
kDa Kilodalton 
l Liter 
LB Lysogeny broth 
LUBAC Linear ubiquitin chain assembly complex 
LZ Lysine-zipper 
m Mili 
M Molarity 
min Minute 
MLKL Mixed Lingase Kinase Ligase 
n Nano 
NBD NEMO binding domain 
Nec-1 Necrostatin-1 
NEMO NF-κB-essential modulator 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cels 
NIK NF-κB-inducing kinase 
NLS Nuclear localization singal 
OPTN Optineurin 
PBS Phosphate bufered saline 
PCD Programmed cel death 
PCR Polymerase chain reaction 
PINK PTEN-induced putative kinase 1 
poly (I:C) Polyinosinic:polycytidylic acid 
PVDF Polyvinylidene difluoride 
qPCR Quantitative real-time polymerase chain reaction 
RIP1 Receptor Interacting Protein 1 
RIP3 Receptor Interacting Protein 3 
RNA Ribonucleic acid 
RT Room temperature 
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sec Second 
shRNA Short hairpin RNA 
siRNA Smal interfering RNA 
Smac Second mitochondria-derives activator of caspases 
SQSTM1 Sequestosome-1 
TAB2 TAK1 binding protein 2 
TAK1 Transforming growth factor β-activated kinase 1 
TANK TRAF family member-associated NF-kappa-B activator 
tBid Truncated Bid 
TBK1 TANK binding kinase 1 
TIR Tol/interleukin-1 receptor 
TL Total cel lysate 
TLR Tol-like receptor 
TNF Tumor necrosis factor 
TNFR TNF receptor 
TRADD TNFR 1-associated death domain protein 
TRAF2 TNF receptor-associated factor 2 
TRAF6 TNF receptor-associated factor 6 
TRIF TIR-domain-containing adapter-inducing interferon-β 
ULD Ubiquitin-like domain 
UV Ultra violet 
V Volt 
w/v Weight per volume 
x g Gravitational acceleration 
XIAP X-linked inhibitor of apoptosis protein 
zVAD-fmk z-Val-Ala-DL-Asp-fluoromethylketone 
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